<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38069362</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>23</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">17039</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms242317039</ELocationID><Abstract><AbstractText>Consistent with well-established biochemical properties of coronaviruses, sialylated glycan attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus's pathology. SARS-CoV-2 SP attaches to and aggregates red blood cells (RBCs), as shown in many pre-clinical and clinical studies, causing pulmonary and extrapulmonary microthrombi and hypoxia in severe COVID-19 patients. SARS-CoV-2 SP attachments to the heavily sialylated surfaces of platelets (which, like RBCs, have no ACE2) and endothelial cells (having minimal ACE2) compound this vascular damage. Notably, experimentally induced RBC aggregation in vivo causes the same key morbidities as for severe COVID-19, including microvascular occlusion, blood clots, hypoxia and myocarditis. Key risk factors for COVID-19 morbidity, including older age, diabetes and obesity, are all characterized by markedly increased propensity to RBC clumping. For mammalian species, the degree of clinical susceptibility to COVID-19 correlates to RBC aggregability with <i>p</i> = 0.033. Notably, of the five human betacoronaviruses, the two common cold strains express an enzyme that releases glycan attachments, while the deadly SARS, SARS-CoV-2 and MERS do not, although viral loads for COVID-19 and the two common cold infections are similar. These biochemical insights also explain the previously puzzling clinical efficacy of certain generics against COVID-19 and may support the development of future therapeutic strategies for COVID-19 and long COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scheim</LastName><ForeName>David E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0001-6841-7054</Identifier><AffiliationInfo><Affiliation>US Public Health Service, Commissioned Corps, Inactive Reserve, Blacksburg, VA 24060, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vottero</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6171-5427</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santin</LastName><ForeName>Alessandro D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-4724-9738</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics, Gynecology &amp; Reproductive Sciences, Yale School of Medicine, P.O. Box 208063, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsh</LastName><ForeName>Allen G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>CryoBioPhysica Inc., Chevy Chase, MD 20815, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011134">Polysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003139" MajorTopicYN="Y">Common Cold</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011134" MajorTopicYN="N">Polysaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">glycophorin A</Keyword><Keyword MajorTopicYN="N">hemagglutination</Keyword><Keyword MajorTopicYN="N">hemagglutinin esterase</Keyword><Keyword MajorTopicYN="N">sialic acid</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword></KeywordList><CoiStatement>A.D.S. reports grants from Verastem Oncology, Puma, Gilead, Synthon, Merck, Boehringer-Ingelheim and Genentech and personal fees for consulting services from TESARO, Eisai, GSK, Merck and Gilead. A.G.H. is the CEO of CryoBioPhysica Inc. The other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>9</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>9</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38069362</ArticleId><ArticleId IdType="pmc">PMC10871123</ArticleId><ArticleId IdType="doi">10.3390/ijms242317039</ArticleId><ArticleId IdType="pii">ijms242317039</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gattinoni L., Gattarello S., Steinberg I., Busana M., Palermo P., Lazzari S., Romitti S., Quintel M., Meissner K., Marini J.J., et al. COVID-19 pneumonia: Pathophysiology and management. Eur. Respir. Rev. 2021;30:210138. doi: 10.1183/16000617.0138-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0138-2021</ArticleId><ArticleId IdType="pmc">PMC8527244</ArticleId><ArticleId IdType="pubmed">34670808</ArticleId></ArticleIdList></Reference><Reference><Citation>Poor H.D. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest. 2021;160:1471&#x2013;1480. doi: 10.1016/j.chest.2021.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8213519</ArticleId><ArticleId IdType="pubmed">34153340</ArticleId></ArticleIdList></Reference><Reference><Citation>Selickman J., Vrettou C.S., Mentzelopoulos S.D., Marini J.J. COVID-19-Related ARDS: Key Mechanistic Features and Treatments. J. Clin. Med. 2022;11:4896. doi: 10.3390/jcm11164896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11164896</ArticleId><ArticleId IdType="pmc">PMC9410336</ArticleId><ArticleId IdType="pubmed">36013135</ArticleId></ArticleIdList></Reference><Reference><Citation>Halawa S., Pullamsetti S.S., Bangham C.R.M., Stenmark K.R., Dorfm&#xfc;ller P., Frid M.G., Butrous G., Morrell N.W., de Jesus Perez V.A., Stuart D.I., et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: A global perspective. Nat. Rev. Cardiol. 2022;19:314&#x2013;331. doi: 10.1038/s41569-021-00640-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00640-2</ArticleId><ArticleId IdType="pmc">PMC8647069</ArticleId><ArticleId IdType="pubmed">34873286</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The mystery of the pandemic&#x2019;s &#x2018;happy hypoxia&#x2019;. Science. 2020;368:455&#x2013;456. doi: 10.1126/science.368.6490.455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.368.6490.455</ArticleId><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini J.J., Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323:2329&#x2013;2330. doi: 10.1001/jama.2020.6825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6825</ArticleId><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Deng Y., Li Z., Dorken Gallastegi A., Mantzoros C.S., Frydman G.H., Karniadakis G.E. Multiphysics and multiscale modeling of microthrombosis in COVID-19. PLoS Comput. Biol. 2022;18:e1009892. doi: 10.1371/journal.pcbi.1009892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1009892</ArticleId><ArticleId IdType="pmc">PMC8901059</ArticleId><ArticleId IdType="pubmed">35255089</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapkiewicz A.V., Mai X., Carsons S.E., Pittaluga S., Kleiner D.E., Berger J.S., Thomas S., Adler N.M., Charytan D.M., Gasmi B., et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. eClinicalMedicine. 2020;24:100434. doi: 10.1016/j.eclinm.2020.100434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100434</ArticleId><ArticleId IdType="pmc">PMC7316051</ArticleId><ArticleId IdType="pubmed">32766543</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.-P., L&#xfc;tgehetmann M., Steurer S., Edler C., Heinemann A., Heinrich F., Mushumba H., Kniep I., Schr&#xf6;der A.S., et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med. 2020;173:268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox S.E., Akmatbekov A., Harbert J.L., Li G., Quincy Brown J., Vander Heide R.S. Pulmonary and cardiac pathology in African American patients with COVID-19: An autopsy series from New Orleans. Lancet Respir. Med. 2020;8:681&#x2013;686. doi: 10.1016/S2213-2600(20)30243-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30243-5</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff T.C., Mohareb A.M., Giri J., Cohen J.B., Chirinos J.A. Thrombosis in COVID-19. Am. J. Hematol. 2020;95:1578&#x2013;1589. doi: 10.1002/ajh.25982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25982</ArticleId><ArticleId IdType="pmc">PMC7674272</ArticleId><ArticleId IdType="pubmed">32857878</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahmy O.H., Daas F.M., Salunkhe V., Petrey J.L., Cosar E.F., Ramirez J., Akca O. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit. Care Explor. 2021;3:e0427. doi: 10.1097/CCE.0000000000000427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000427</ArticleId><ArticleId IdType="pmc">PMC8140776</ArticleId><ArticleId IdType="pubmed">34036278</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T., Haslbauer J.D., Nienhold R., Savic S., Hopfer H., Deigendesch N., Frank S., Turek D., Willi N., Pargger H., et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198&#x2013;209. doi: 10.1111/his.14134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14134</ArticleId><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen J.D., Stevens H., Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ. Res. 2020;127:571&#x2013;587. doi: 10.1161/CIRCRESAHA.120.317447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317447</ArticleId><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Poh K.C., Jia Tay V.Y., Lin S.H., Chee H.L., Thangavelautham S. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population. Singap. Med. J. 2022;63:350&#x2013;361. doi: 10.11622/smedj.2020174.</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2020174</ArticleId><ArticleId IdType="pmc">PMC9578119</ArticleId><ArticleId IdType="pubmed">33264831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Schneider E., Zentilin L., Collesi C., Ali H., Braga L., Volpe M.C., Colliva A., Zanconati F., Berlot G., et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. eBioMedicine. 2020;61:103104. doi: 10.1016/j.ebiom.2020.103104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103104</ArticleId><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Overton P.M., Toshner M., Mulligan C., Vora P., Nikkho S., de Backer J., Lavon B.R., Klok F.A., the PVRI Innovative Drug Development Initiative Pulmonary thromboembolic events in COVID-19&#x2014;A systematic literature review. Pulm. Circ. 2022;12:e12113. doi: 10.1002/pul2.12113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pul2.12113</ArticleId><ArticleId IdType="pmc">PMC9349961</ArticleId><ArticleId IdType="pubmed">35942076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini D., Kawakami R., Guagliumi G., Sakamoto A., Kawai K., Gianatti A., Nasr A., Kutys R., Guo L., Cornelissen A., et al. Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. Circulation. 2021;143:1031&#x2013;1042. doi: 10.1161/CIRCULATIONAHA.120.051828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.051828</ArticleId><ArticleId IdType="pubmed">33480806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowenstein C.J., Solomon S.D. Severe COVID-19 Is a Microvascular Disease. Circulation. 2020;142:1609&#x2013;1611. doi: 10.1161/CIRCULATIONAHA.120.050354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050354</ArticleId><ArticleId IdType="pmc">PMC7580651</ArticleId><ArticleId IdType="pubmed">32877231</ArticleId></ArticleIdList></Reference><Reference><Citation>Price L.C., McCabe C., Garfield B., Wort S.J. Thrombosis and COVID-19 pneumonia: The clot thickens! Eur. Respir. J. 2020;56:2001608. doi: 10.1183/13993003.01608-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01608-2020</ArticleId><ArticleId IdType="pmc">PMC7301830</ArticleId><ArticleId IdType="pubmed">32554532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Lapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., Kucher N., Studt J.D., Sacco C., Alexia B., et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9&#x2013;14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., Baxter-Stoltzfus A., Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl. Res. 2020;220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez J., Albaiceta G.M., Garc&#xed;a-Clemente M., L&#xf3;pez-Larrea C., Amado-Rodr&#xed;guez L., Lopez-Alonso I., Hermida T., Enriquez A.I., Herrero P., Mel&#xf3;n S., et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020;762:145102. doi: 10.1016/j.gene.2020.145102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2020.145102</ArticleId><ArticleId IdType="pmc">PMC7456966</ArticleId><ArticleId IdType="pubmed">32882331</ArticleId></ArticleIdList></Reference><Reference><Citation>Aung A.K., Aitken T., Teh B.M., Yu C., Ofori-Asenso R., Chin K.L., Liew D. Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study. J. Infect. 2020;81:961&#x2013;965. doi: 10.1016/j.jinf.2020.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.11.012</ArticleId><ArticleId IdType="pmc">PMC7666537</ArticleId><ArticleId IdType="pubmed">33197472</ArticleId></ArticleIdList></Reference><Reference><Citation>Abassi Z., Higazi A.A.R., Kinaneh S., Armaly Z., Skorecki K., Heyman S.N. ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle. Front. Physiol. 2020;11:574753. doi: 10.3389/fphys.2020.574753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.574753</ArticleId><ArticleId IdType="pmc">PMC7573220</ArticleId><ArticleId IdType="pubmed">33123031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Montano M., Corley M.J., Helmy E., Kobayashi H., Kinisu M., Suryawanshi R., Luo X., Royer L.A., Roan N.R., et al. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. mBio. 2022;13:e0230822. doi: 10.1128/mbio.02308-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02308-22</ArticleId><ArticleId IdType="pmc">PMC9765283</ArticleId><ArticleId IdType="pubmed">36314791</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulswit R.J.G., de Haan C.A.M., Bosch B.J. Chapter Two&#x2014;Coronavirus Spike Protein and Tropism Changes. In: Ziebuhr J., editor. Advances in Virus Research. Volume 96. Academic Press; New York, NY, USA: 2016. pp. 29&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112277</ArticleId><ArticleId IdType="pubmed">27712627</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int. J. Mol. Sci. 2022;23:2558. doi: 10.3390/ijms23052558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052558</ArticleId><ArticleId IdType="pmc">PMC8910562</ArticleId><ArticleId IdType="pubmed">35269703</ArticleId></ArticleIdList></Reference><Reference><Citation>Matrosovich M., Herrler G., Klenk H.D. Sialic Acid Receptors of Viruses. In: Gerardy-Schahn R., Delannoy P., von Itzstein M., editors. SialoGlyco Chemistry and Biology II: Tools and Techniques to Identify and Capture Sialoglycans. Springer International Publishing; New York, NY, USA: 2015. pp. 1&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7120183</ArticleId><ArticleId IdType="pubmed">23873408</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorici M.A., Walls A.C., Lang Y., Wang C., Li Z., Koerhuis D., Boons G.J., Bosch B.J., Rey F.A., de Groot R.J., et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 2019;26:481&#x2013;489. doi: 10.1038/s41594-019-0233-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0233-y</ArticleId><ArticleId IdType="pmc">PMC6554059</ArticleId><ArticleId IdType="pubmed">31160783</ArticleId></ArticleIdList></Reference><Reference><Citation>Unione L., Moure M.J., Lenza M.P., Oyenarte I., Ere&#xf1;o-Orbea J., Ard&#xe1; A., Jim&#xe9;nez-Barbero J. The SARS-CoV-2 Spike Glycoprotein Directly Binds Exogeneous Sialic Acids: A NMR View. Angew. Chem. Int. Ed. 2022;61:e202201432. doi: 10.1002/anie.202201432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202201432</ArticleId><ArticleId IdType="pmc">PMC9074024</ArticleId><ArticleId IdType="pubmed">35191576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapikian A.Z., James H.D., Jr., Kelly S.J., King L.M., Vaughn A.L., Chanock R.M. Hemadsorption by coronavirus strain OC43. Proc. Soc. Exp. Biol. Med. 1972;139:179&#x2013;186. doi: 10.3181/00379727-139-36105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-139-36105</ArticleId><ArticleId IdType="pubmed">4621400</ArticleId></ArticleIdList></Reference><Reference><Citation>Agafonov A.P., Gus&#x2019;kov A.A., Ternovoi V.A., Ryabchikova E.I., Durymanov A.G., Vinogradov I.V., Maksimov N.L., Ignat&#x2019;ev G.M., Nechaeva E.A., Netesov S.V. Primary characterization of SARS coronavirus strain Frankfurt 1. Dokl. Biol. Sci. 2004;394:58&#x2013;60. doi: 10.1023/B:DOBS.0000017131.06970.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:DOBS.0000017131.06970.74</ArticleId><ArticleId IdType="pmc">PMC7088183</ArticleId><ArticleId IdType="pubmed">15088406</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasak R., Luytjes W., Spaan W., Palese P. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc. Natl. Acad. Sci. USA. 1988;85:4526&#x2013;4529. doi: 10.1073/pnas.85.12.4526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.12.4526</ArticleId><ArticleId IdType="pmc">PMC280463</ArticleId><ArticleId IdType="pubmed">3380803</ArticleId></ArticleIdList></Reference><Reference><Citation>Storz J., Zhang X.M., Rott R. Comparison of hemagglutinating, receptor-destroying, and acetylesterase activities of avirulent and virulent bovine coronavirus strains. Arch. Virol. 1992;125:193&#x2013;204. doi: 10.1007/BF01309637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01309637</ArticleId><ArticleId IdType="pmc">PMC7087242</ArticleId><ArticleId IdType="pubmed">1642550</ArticleId></ArticleIdList></Reference><Reference><Citation>Brian D.A., Hogue B.G., Kienzle T.E. The Coronavirus Hemagglutinin Esterase Glycoprotein. In: Siddell S.G., editor. The Coronaviridae. The Viruses. Springer; Boston, MA, USA: 1995.</Citation></Reference><Reference><Citation>Qing E., Hantak M., Perlman S., Gallagher T. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. mBio. 2020;11:e02764-19. doi: 10.1128/mBio.02764-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02764-19</ArticleId><ArticleId IdType="pmc">PMC7018658</ArticleId><ArticleId IdType="pubmed">32047128</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze B., Cavanagh D., Herrler G. Neuraminidase treatment of avian infectious bronchitis coronavirus reveals a hemagglutinating activity that is dependent on sialic acid-containing receptors on erythrocytes. Virology. 1992;189:792&#x2013;794. doi: 10.1016/0042-6822(92)90608-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(92)90608-R</ArticleId><ArticleId IdType="pmc">PMC7131420</ArticleId><ArticleId IdType="pubmed">1322604</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Hulswit R.J.G., Widjaja I., Raj V.S., McBride R., Peng W., Widagdo W., Tortorici M.A., van Dieren B., Lang Y., et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc. Natl. Acad. Sci. USA. 2017;114:E8508&#x2013;E8517. doi: 10.1073/pnas.1712592114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1712592114</ArticleId><ArticleId IdType="pmc">PMC5635925</ArticleId><ArticleId IdType="pubmed">28923942</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulswit R.J.G., Lang Y., Bakkers M.J.G., Li W., Li Z., Schouten A., Ophorst B., van Kuppeveld F.J.M., Boons G.J., Bosch B.J., et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl. Acad. Sci. USA. 2019;116:2681&#x2013;2690. doi: 10.1073/pnas.1809667116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809667116</ArticleId><ArticleId IdType="pmc">PMC6377473</ArticleId><ArticleId IdType="pubmed">30679277</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu U., Bauer J., Stehle T. Viruses and sialic acids: Rules of engagement. Curr. Opin. Struct. Biol. 2011;21:610&#x2013;618. doi: 10.1016/j.sbi.2011.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2011.08.009</ArticleId><ArticleId IdType="pmc">PMC3189341</ArticleId><ArticleId IdType="pubmed">21917445</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Dong W., Milewska A., Golda A., Qi Y., Zhu Q.K., Marasco W.A., Baric R.S., Sims A.C., Pyrc K., et al. Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme. J. Virol. 2015;89:7202&#x2013;7213. doi: 10.1128/JVI.00854-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00854-15</ArticleId><ArticleId IdType="pmc">PMC4473545</ArticleId><ArticleId IdType="pubmed">25926653</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y.-J., Walls A.C., Wang Z., Sauer M.M., Li W., Tortorici M.A., Bosch B.-J., DiMaio F., Veesler D. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 2019;26:1151&#x2013;1157. doi: 10.1038/s41594-019-0334-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0334-7</ArticleId><ArticleId IdType="pmc">PMC7097669</ArticleId><ArticleId IdType="pubmed">31792450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wielgat P., Rogowski K., Godlewska K., Car H. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects. Cells. 2020;9:1963. doi: 10.3390/cells9091963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9091963</ArticleId><ArticleId IdType="pmc">PMC7564400</ArticleId><ArticleId IdType="pubmed">32854433</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler M., Delguste M., Sieben C., Gillet L., Alsteens D. Initial Step of Virus Entry: Virion Binding to Cell-Surface Glycans. Annu. Rev. Virol. 2020;7:143&#x2013;165. doi: 10.1146/annurev-virology-122019-070025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-122019-070025</ArticleId><ArticleId IdType="pubmed">32396772</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf6;h L.J., Stehle T. Glycan Engagement by Viruses: Receptor Switches and Specificity. Annu. Rev. Virol. 2014;1:285&#x2013;306. doi: 10.1146/annurev-virology-031413-085417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-031413-085417</ArticleId><ArticleId IdType="pubmed">26958723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.F.-W., Kok K.-H., Zhu Z., Chu H., To K.K.-W., Yuan S., Yuen K.-Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9:221&#x2013;236. doi: 10.1080/22221751.2020.1719902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1719902</ArticleId><ArticleId IdType="pmc">PMC7067204</ArticleId><ArticleId IdType="pubmed">31987001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92:418&#x2013;423. doi: 10.1002/jmv.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814&#x2013;1820. doi: 10.1056/NEJMoa1211721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211721</ArticleId><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Nyodu R., Maurya V.K., Saxena S.K. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In: Saxena S.K., editor. Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Springer; Singapore: 2020. pp. 23&#x2013;31.</Citation></Reference><Reference><Citation>Yoshimoto F.K. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020;39:198&#x2013;216. doi: 10.1007/s10930-020-09901-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09901-4</ArticleId><ArticleId IdType="pmc">PMC7245191</ArticleId><ArticleId IdType="pubmed">32447571</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacot D., Greub G., Jaton K., Opota O. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses. Microbes Infect. 2020;22:617&#x2013;621. doi: 10.1016/j.micinf.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7476607</ArticleId><ArticleId IdType="pubmed">32911086</ArticleId></ArticleIdList></Reference><Reference><Citation>Shajahan A., Supekar N.T., Gleinich A.S., Azadi P. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology. 2020;30:981&#x2013;988. doi: 10.1093/glycob/cwaa042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwaa042</ArticleId><ArticleId IdType="pmc">PMC7239183</ArticleId><ArticleId IdType="pubmed">32363391</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Lakshminarayanan H., Rodriguez-Palacios A., Salata R.A., Xu K., Draz M.S. Glycan Nanostructures of Human Coronaviruses. Int. J. Nanomed. 2021;16:4813&#x2013;4830. doi: 10.2147/IJN.S302516.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S302516</ArticleId><ArticleId IdType="pmc">PMC8289332</ArticleId><ArticleId IdType="pubmed">34290504</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.K., Cao Y., Frank M., Woo H., Park S.-J., Yeom M.S., Croll T.I., Seok C., Im W. Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane. J. Chem. Theory Comput. 2021;17:2479&#x2013;2487. doi: 10.1021/acs.jctc.0c01144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.0c01144</ArticleId><ArticleId IdType="pmc">PMC8047829</ArticleId><ArticleId IdType="pubmed">33689337</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker A.N., Richards S.-J., Guy C.S., Congdon T.R., Hasan M., Zwetsloot A.J., Gallo A., Lewandowski J.R., Stansfeld P.J., Straube A., et al. The SARS-CoV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device. ACS Cent. Sci. 2020;6:2046&#x2013;2052. doi: 10.1021/acscentsci.0c00855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c00855</ArticleId><ArticleId IdType="pmc">PMC7523238</ArticleId><ArticleId IdType="pubmed">33269329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardone R.D., Garay Y.C., Parodi P., de la Fuente S., Angeloni G., Bravo E.O., Schmider A.K., Irazoqui F.J. How glycobiology can help us treat and beat the COVID-19 pandemic. J. Biol. Chem. 2021;296:100375. doi: 10.1016/j.jbc.2021.100375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100375</ArticleId><ArticleId IdType="pmc">PMC7857991</ArticleId><ArticleId IdType="pubmed">33548227</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C., Zeng J., Jia N., Stavenhagen K., Matsumoto Y., Zhang H., Li J., Hume A.J., M&#xfc;hlberger E., van Die I., et al. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors. bioRxiv. 2020 doi: 10.1101/2020.07.29.227462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.29.227462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Hui Z., Ren X., Luo Y., Shu J., Yu H., Li Z. The N-glycosylation sites and Glycan-binding ability of S-protein in SARS-CoV-2 Coronavirus. bioRxiv. :2020. doi: 10.1101/2020.12.01.406025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.01.406025</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalino L., Gaieb Z., Goldsmith J.A., Hjorth C.K., Dommer A.C., Harbison A.M., Fogarty C.A., Barros E.P., Taylor B.C., McLellan J.S., et al. Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein. ACS Cent. Sci. 2020;6:1722&#x2013;1734. doi: 10.1021/acscentsci.0c01056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01056</ArticleId><ArticleId IdType="pmc">PMC7523240</ArticleId><ArticleId IdType="pubmed">33140034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyv&#xe4;rinen S., Meri S., Jokiranta T.S. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome. Blood. 2016;127:2701&#x2013;2710. doi: 10.1182/blood-2015-11-680009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2015-11-680009</ArticleId><ArticleId IdType="pubmed">27006390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasinrerk W., Tokrasinwit N., Phunpae P. CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology. 1999;96:184&#x2013;192. doi: 10.1046/j.1365-2567.1999.00653.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.1999.00653.x</ArticleId><ArticleId IdType="pmc">PMC2326738</ArticleId><ArticleId IdType="pubmed">10233694</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell R.A., Boilard E., Rondina M.T. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J. Thromb. Haemost. 2021;19:46&#x2013;50. doi: 10.1111/jth.15156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15156</ArticleId><ArticleId IdType="pmc">PMC7899240</ArticleId><ArticleId IdType="pubmed">33119197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosic I., Cosic D., Loncarevic I. RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus. Appl. Sci. 2020;10:4053. doi: 10.3390/app10114053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app10114053</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E., From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature  OSF Preprints.  [(accessed on 30 October 2023)].  Available online:  https://osf.io/sgdj2.</Citation></Reference><Reference><Citation>Ahmetaj-Shala B., Vaja R., Atanur S., George P., Kirkby N., Mitchell J. Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells. bioRxiv. 2020 doi: 10.1101/2020.06.23.165324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.23.165324</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Satchell S.C., Neal C.R., McKenzie E.A., Tooke J.E., Mathieson P.W. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J. Am. Soc. Nephrol. 2007;18:2885&#x2013;2893. doi: 10.1681/ASN.2007010119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2007010119</ArticleId><ArticleId IdType="pubmed">17942961</ArticleId></ArticleIdList></Reference><Reference><Citation>Viitala J., J&#xe4;rnefelt J. The red cell surface revisited. Trends Biochem. Sci. 1985;10:392&#x2013;395. doi: 10.1016/0968-0004(85)90067-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0968-0004(85)90067-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum J., Ward R.H., Conway D.J. Natural selection on the erythrocyte surface. Mol. Biol. Evol. 2002;19:223&#x2013;229. doi: 10.1093/oxfordjournals.molbev.a004075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.molbev.a004075</ArticleId><ArticleId IdType="pubmed">11861881</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine S., Levine M., Sharp K.A., Brooks D.E. Theory of the electrokinetic behavior of human erythrocytes. Biophys. J. 1983;42:127&#x2013;135. doi: 10.1016/S0006-3495(83)84378-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(83)84378-1</ArticleId><ArticleId IdType="pmc">PMC1329215</ArticleId><ArticleId IdType="pubmed">6860771</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki T. A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins. Membranes. 2017;7:56. doi: 10.3390/membranes7040056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/membranes7040056</ArticleId><ArticleId IdType="pmc">PMC5746815</ArticleId><ArticleId IdType="pubmed">28961212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D. Why are glycoproteins modified by poly-N-acetyllactosamine glyco-conjugates? Curr. Protein Pept. Sci. 2003;4:1&#x2013;9. doi: 10.2174/1389203033380304.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203033380304</ArticleId><ArticleId IdType="pubmed">12570780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda M., Dell A., Oates J.E., Fukuda M.N. Structure of branched lactosaminoglycan, the carbohydrate moiety of band 3 isolated from adult human erythrocytes. J. Biol. Chem. 1984;259:8260&#x2013;8273. doi: 10.1016/S0021-9258(17)39722-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)39722-3</ArticleId><ArticleId IdType="pubmed">6736034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bua R.O., Messina A., Sturiale L., Barone R., Garozzo D., Palmigiano A. N-Glycomics of Human Erythrocytes. Int. J. Mol. Sci. 2021;22:8063. doi: 10.3390/ijms22158063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158063</ArticleId><ArticleId IdType="pmc">PMC8347577</ArticleId><ArticleId IdType="pubmed">34360826</ArticleId></ArticleIdList></Reference><Reference><Citation>Liukkonen J., Haataja S., Tikkanen K., Kelm S., Finne J. Identification of N-acetylneuraminyl alpha 2--&gt;3 poly-N-acetyllactosamine glycans as the receptors of sialic acid-binding Streptococcus suis strains. J. Biol. Chem. 1992;267:21105&#x2013;21111. doi: 10.1016/S0021-9258(19)36803-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)36803-6</ArticleId><ArticleId IdType="pubmed">1400420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nycholat C.M., McBride R., Ekiert D.C., Xu R., Rangarajan J., Peng W., Razi N., Gilbert M., Wakarchuk W., Wilson I.A., et al. Recognition of Sialylated Poly-N-acetyllactosamine Chains on N- and O-Linked Glycans by Human and Avian Influenza|A Virus Hemagglutinins. Angew. Chem. Int. Ed. 2012;51:4860&#x2013;4863. doi: 10.1002/anie.201200596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201200596</ArticleId><ArticleId IdType="pmc">PMC3517101</ArticleId><ArticleId IdType="pubmed">22505324</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul R.W., Lee P.W.K. Glycophorin is the reovirus receptor on human erythrocytes. Virology. 1987;159:94&#x2013;101. doi: 10.1016/0042-6822(87)90351-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90351-5</ArticleId><ArticleId IdType="pubmed">3604060</ArticleId></ArticleIdList></Reference><Reference><Citation>Korhonen T.K., Haahtela K., Pirkola A., Parkkinen J. A N-acetyllactosamine-specific cell-binding activity in a plant pathogen, Erwinia rhapontici. FEBS Lett. 1988;236:163&#x2013;166. doi: 10.1016/0014-5793(88)80307-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(88)80307-7</ArticleId><ArticleId IdType="pubmed">2456952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson D.S. Immune Adherence. In: Dixon F.J., Humphrey J.H., editors. Advances in Immunology. Volume 3. Academic Press; Cambridge, MA, USA: 1963. pp. 131&#x2013;180.</Citation></Reference><Reference><Citation>Anderson H.L., Brodsky I.E., Mangalmurti N.S. The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity. J. Immunol. 2018;201:1343&#x2013;1351. doi: 10.4049/jimmunol.1800565.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800565</ArticleId><ArticleId IdType="pmc">PMC6108441</ArticleId><ArticleId IdType="pubmed">30127064</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki A., Gagneux P. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 2012;1253:16&#x2013;36. doi: 10.1111/j.1749-6632.2012.06517.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2012.06517.x</ArticleId><ArticleId IdType="pmc">PMC3357316</ArticleId><ArticleId IdType="pubmed">22524423</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson R.A. The Immune-Adherence Phenomenon: An Immunologically Specific Reaction Between Microorganisms and Erythrocytes Leading to Enhanced Phagocytosis. Science. 1953;118:733&#x2013;737. doi: 10.1126/science.118.3077.733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.118.3077.733</ArticleId><ArticleId IdType="pubmed">13122009</ArticleId></ArticleIdList></Reference><Reference><Citation>De Back D.Z., Kostova E., Klei T., Beuger B., van Zwieten R., Kuijpers T., Juffermans N., van den Berg T., Korte D., van Kraaij M., et al. RBC Adhesive Capacity Is Essential for Efficient &#x2018;Immune Adherence Clearance&#x2019; and Provide a Generic Target to Deplete Pathogens from Septic Patients. Blood. 2016;128:1031. doi: 10.1182/blood.V128.22.1031.1031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V128.22.1031.1031</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel I., Lin Liu T., Gleicher N. The Red-Cell Immune System. Lancet. 1981;318:556&#x2013;559. doi: 10.1016/S0140-6736(81)90941-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(81)90941-7</ArticleId><ArticleId IdType="pubmed">6116004</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocker T.J., Ishikawa-Ankerhold H., Massberg S., Schulz C. Small but mighty: Platelets as central effectors of host defense. Thromb. Haemost. 2017;117:651&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">28203681</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas N.D., Tolia N.H. Red cell receptors as access points for malaria infection. Curr. Opin. Hematol. 2016;23:215&#x2013;223. doi: 10.1097/MOH.0000000000000219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000219</ArticleId><ArticleId IdType="pmc">PMC4964589</ArticleId><ArticleId IdType="pubmed">26766537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikora M., von B&#xfc;low S., Blanc F.E.C., Gecht M., Covino R., Hummer G. Computational epitope map of SARS-CoV-2 spike protein. PLoS Comput. Biol. 2021;17:e1008790. doi: 10.1371/journal.pcbi.1008790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008790</ArticleId><ArticleId IdType="pmc">PMC8016105</ArticleId><ArticleId IdType="pubmed">33793546</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschi C., Scheim D.E., Bancod A., Militello M., Bideau M.L., Colson P., Fantini J., Scola B.L. SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int. J. Mol. Sci. 2022;23:15480. doi: 10.3390/ijms232415480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415480</ArticleId><ArticleId IdType="pmc">PMC9779393</ArticleId><ArticleId IdType="pubmed">36555121</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid M.E., Mohandas N. Red blood cell blood group antigens: Structure and function. Semin. Hematol. 2004;41:93&#x2013;117. doi: 10.1053/j.seminhematol.2004.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminhematol.2004.01.001</ArticleId><ArticleId IdType="pubmed">15071789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretini V., Koenen M.H., Kaestner L., Fens M.H.A.M., Schiffelers R.M., Bartels M., Van Wijk R. Red Blood Cells: Chasing Interactions. Front. Physiol. 2019;10:945. doi: 10.3389/fphys.2019.00945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00945</ArticleId><ArticleId IdType="pmc">PMC6684843</ArticleId><ArticleId IdType="pubmed">31417415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaskiewicz E., Jod&#x142;owska M., Kaczmarek R., Zerka A. Erythrocyte glycophorins as receptors for Plasmodium merozoites. Parasites Vectors. 2019;12:317. doi: 10.1186/s13071-019-3575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-019-3575-8</ArticleId><ArticleId IdType="pmc">PMC6591965</ArticleId><ArticleId IdType="pubmed">31234897</ArticleId></ArticleIdList></Reference><Reference><Citation>Varki A., Schnaar R.L., Schauer R. Chapter 15: Sialic Acids and Other Nonulosonic Acids. In: Varki A., Cummings R., Esko J., editors. Essentials of Glycobiology. 3rd ed. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY, USA: 2017.</Citation></Reference><Reference><Citation>Soares C.O., Grosso A.S., Ere&#xf1;o-Orbea J., Coelho H., Marcelo F. Molecular Recognition Insights of Sialic Acid Glycans by Distinct Receptors Unveiled by NMR and Molecular Modeling. Front. Mol. Biosci. 2021;8:727847. doi: 10.3389/fmolb.2021.727847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.727847</ArticleId><ArticleId IdType="pmc">PMC8634706</ArticleId><ArticleId IdType="pubmed">34869580</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M., Varki A. Chapter Three&#x2014;Modulation of Glycan Recognition by Clustered Saccharide Patches. In: Jeon K.W., editor. International Review of Cell and Molecular Biology. Volume 308. Academic Press; Cambridge, MA, USA: 2014. pp. 75&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">24411170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M., Varki A. The sialome&#x2014;Far more than the sum of its parts. Omics. 2010;14:455&#x2013;464. doi: 10.1089/omi.2009.0148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2009.0148</ArticleId><ArticleId IdType="pubmed">20726801</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminpour M., Cannariato M., Safaeeardebili M.E., Preto J., Moracchiato A., Doria D., Donato F., Zizzi E.A., Deriu M.A., Scheim D.E., et al. In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds. Computation. 2022;10:51. doi: 10.3390/computation10040051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/computation10040051</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa N., Vanbeselaere J., Chang L.-Y., Yu S.-Y., Ducrocq L., Harduin-Lepers A., Kurata J., Aoki-Kinoshita K.F., Sato C., Khoo K.-H., et al. Systems glycomics of adult zebrafish identifies organ-specific sialylation and glycosylation patterns. Nat. Commun. 2018;9:4647. doi: 10.1038/s41467-018-06950-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06950-3</ArticleId><ArticleId IdType="pmc">PMC6220181</ArticleId><ArticleId IdType="pubmed">30405127</ArticleId></ArticleIdList></Reference><Reference><Citation>Au Sam H., Storey Brian D., Moore John C., Tang Q., Chen Y.-L., Javaid S., Sarioglu A.F., Sullivan R., Madden Marissa W., O&#x2019;Keefe R., et al. Clusters of circulating tumor cells traverse capillary-sized vessels. Proc. Natl. Acad. Sci. USA. 2016;113:4947&#x2013;4952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4983862</ArticleId><ArticleId IdType="pubmed">27091969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Zhao J., Li J., Guo Z., Sheng J., Ye X., Jin G., Wang C., Chai W., Yan J., et al. SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. Int. J. Biol. Macromol. 2021;193:1124&#x2013;1129. doi: 10.1016/j.ijbiomac.2021.10.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.10.112</ArticleId><ArticleId IdType="pmc">PMC8553634</ArticleId><ArticleId IdType="pubmed">34743814</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta Y., Maciorowski D., Zak S.E., Kulkarni C.V., Herbert A.S., Durvasula R., Fareed J., Dye J.M., Kempaiah P. Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. Int. J. Biol. Macromol. 2021;183:203&#x2013;212. doi: 10.1016/j.ijbiomac.2021.04.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.04.148</ArticleId><ArticleId IdType="pmc">PMC8074525</ArticleId><ArticleId IdType="pubmed">33915212</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayer M.R. Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach. J. Epigenet. 2021;2:31&#x2013;38.</Citation></Reference><Reference><Citation>Melkumyants A., Buryachkovskaya L., Lomakin N., Antonova O., Serebruany V. Mild COVID-19 and Impaired Blood Cell&#x2013;Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics? Thromb. Haemost. 2022;122:123&#x2013;130. doi: 10.1055/a-1551-9911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9911</ArticleId><ArticleId IdType="pubmed">34482535</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzuini A., Bianco C., Migliorini A.C., Maggioni M., Valenti L., Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus. 2021;19:34&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850925</ArticleId><ArticleId IdType="pubmed">32955421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Maley A.M., Wu C., Gilboa T., Norman M., Lazarovits R., Mao C.P., Newton G., Chang M., Nguyen K., et al. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin. Chem. 2020;66:1562&#x2013;1572. doi: 10.1093/clinchem/hvaa213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa213</ArticleId><ArticleId IdType="pmc">PMC7499543</ArticleId><ArticleId IdType="pubmed">32897389</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Morigi M., Galbusera M., Pezzotta A., Gastoldi S., Imberti B., Perna A., Ruggenenti P., Donadelli R., Benigni A., et al. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front. Immunol. 2022;13:827146. doi: 10.3389/fimmu.2022.827146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.827146</ArticleId><ArticleId IdType="pmc">PMC8936079</ArticleId><ArticleId IdType="pubmed">35320941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo G.J., Magro C., Shaffer T., Awad H., Suster D., Mikhail S., He B., Michaille J.-J., Liechty B., Tili E. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann. Diagn. Pathol. 2021;51:151682. doi: 10.1016/j.anndiagpath.2020.151682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating SARS-CoV-2 spike Is associated With post-acute COVID-19 sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Spikes L., Krishnamachary B., Ram A.K., Kumar A., Chen L., Chalise P., Dhillon N.K. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Bosurgi L., Dutzmann J., Sedding D., Frese T., Girndt M., et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. 2023;95:e28364. doi: 10.1002/jmv.28364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28364</ArticleId><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS-CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:5526. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah M.M., Bernier A., Buchrieser J., Schwartz O. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation. J. Mol. Biol. 2021;434:167280. doi: 10.1016/j.jmb.2021.167280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167280</ArticleId><ArticleId IdType="pmc">PMC8485708</ArticleId><ArticleId IdType="pubmed">34606831</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattin-Ortol&#xe1; J., Welch L.G., Maslen S.L., Papa G., James L.C., Munro S. Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation. Nat. Commun. 2021;12:5333. doi: 10.1038/s41467-021-25589-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25589-1</ArticleId><ArticleId IdType="pmc">PMC8429659</ArticleId><ArticleId IdType="pubmed">34504087</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front. Immunol. 2020;11:576622. doi: 10.3389/fimmu.2020.576622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576622</ArticleId><ArticleId IdType="pmc">PMC7575906</ArticleId><ArticleId IdType="pubmed">33117378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam L.K.M., Reilly J.P., Rux A.H., Murphy S.J., Kuri-Cervantes L., Weisman A.R., Ittner C.A.G., Pampena M.B., Betts M.R., Wherry E.J., et al. Erythrocytes identify complement activation in patients with COVID-19. Am. J. Physiol. Lung Cell Mol. Physiol. 2021;321:L485&#x2013;L489. doi: 10.1152/ajplung.00231.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00231.2021</ArticleId><ArticleId IdType="pmc">PMC8384475</ArticleId><ArticleId IdType="pubmed">34231390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J.-Q., Du P., Wei D., Zhang Y., Sun X.-X., Gong L., et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 2020;5:283. doi: 10.1038/s41392-020-00426-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00426-x</ArticleId><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao W., Ma B., Li Z., Wang X., Gao X., Li Y., Qin B., Shang S., Cui S., Tan Z. Binding of the SARS-CoV-2 spike protein to glycans. Sci. Bull. (Beijing) 2021;66:1205&#x2013;1214. doi: 10.1016/j.scib.2021.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2021.01.010</ArticleId><ArticleId IdType="pmc">PMC7816574</ArticleId><ArticleId IdType="pubmed">33495714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilts J., Crozier T.W.M., Greenwood E.J.D., Lehner P.J., Wright G.J. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci. Rep. 2021;11:413. doi: 10.1038/s41598-020-80464-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80464-1</ArticleId><ArticleId IdType="pmc">PMC7801465</ArticleId><ArticleId IdType="pubmed">33432067</ArticleId></ArticleIdList></Reference><Reference><Citation>Buryachkovskaya L., Lomakin N., Melkumyants A., Docenko J., Ermishkin V., Serebruany V. Enoxaparin dose impacts blood cell phenotypes during mild SARS-CoV-2 infection: The observational single-center study. Rev. Cardiovasc. Med. 2021;22:1685&#x2013;1691. doi: 10.31083/j.rcm2204176.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2204176</ArticleId><ArticleId IdType="pubmed">34957811</ArticleId></ArticleIdList></Reference><Reference><Citation>Melkumyants A., Buryachkovskaya L., Lomakin N., Antonova O., Docenko J., Ermishkin V., Serebruany V. Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19. J. Clin. Med. 2022;11:1995. doi: 10.3390/jcm11071995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071995</ArticleId><ArticleId IdType="pmc">PMC8999543</ArticleId><ArticleId IdType="pubmed">35407602</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaron E., Ince C., Hilty M.P., Ergin B., van der Zee P., Uz Z., Wendel Garcia P.D., Hofmaenner D.A., Acevedo C.T., van Boven W.J., et al. Capillary Leukocytes, Microaggregates, and the Response to Hypoxemia in the Microcirculation of Coronavirus Disease 2019 Patients. Crit. Care Med. 2021;49:661&#x2013;670. doi: 10.1097/CCM.0000000000004862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004862</ArticleId><ArticleId IdType="pmc">PMC7963442</ArticleId><ArticleId IdType="pubmed">33405410</ArticleId></ArticleIdList></Reference><Reference><Citation>Nader E., Nougier C., Boisson C., Poutrel S., Catella J., Martin F., Charvet J., Girard S., Havard-Guibert S., Martin M., et al. Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Am. J. Hematol. 2022;97:283&#x2013;292. doi: 10.1002/ajh.26440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26440</ArticleId><ArticleId IdType="pubmed">34939698</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli C.M., Jones S.A., Yang J., Rajagopalan H., O&#x2019;Donnell L., Chernyak Y., Tobin K.A., Cerfolio R.J., Francois F., Horwitz L.I. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ. 2020;369:m1966. doi: 10.1136/bmj.m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G., Riri K., Boutlas S., Panagiotou T.N., Kotoula M., Daniil Z., Tsironi E.E. COVID-19 hemodynamic and thrombotic effect on the eye microcirculation after hospitalization: A quantitative case-control study. Clin. Hemorheol. Microcirc. 2022;82:379&#x2013;390. doi: 10.3233/CH-221554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-221554</ArticleId><ArticleId IdType="pubmed">35912735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko C.J., Harigopal M., Gehlhausen J.R., Bosenberg M., McNiff J.M., Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J. Cutan. Pathol. 2021;48:47&#x2013;52. doi: 10.1111/cup.13866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.13866</ArticleId><ArticleId IdType="pubmed">32895985</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Han K., Blair R., Kenst K., Qin Z., Upcin B., W&#xf6;rsd&#xf6;rfer P., Midkiff C.C., Mudd J., Belyaeva E., et al. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro. Front. Cell. Infect. Microbiol. 2021;11:701278. doi: 10.3389/fcimb.2021.701278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.701278</ArticleId><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C.M., Mulvey J.J., Laurence J., Seshan S., Crowson A.N., Dannenberg A.J., Salvatore S., Harp J., Nuovo G.J. Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019. Hum. Pathol. 2020;106:106&#x2013;116. doi: 10.1016/j.humpath.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7550120</ArticleId><ArticleId IdType="pubmed">33058948</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Benigni A., Remuzzi G. SARS-CoV-2 and the spike protein in endotheliopathy. Trends Microbiol. 2023 doi: 10.1016/j.tim.2023.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2023.06.004</ArticleId><ArticleId IdType="pmc">PMC10258582</ArticleId><ArticleId IdType="pubmed">37393180</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G., Pine A.B., Meizlish M.L., Chang C.H., Zhang H., Bahel P., Baluha A., Bar N., Bona R.D., Burns A.J., et al. Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., Guignabert C., Humbert M. Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)? Eur. Respir. J. 2020;56:2001634. doi: 10.1183/13993003.01634-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhl L., He L., Sun Y., Andaloussi M&#xe4;e M., Pietil&#xe4; R., Liu J., Genov&#xe9; G., Zhang L., Xie Y., Leptidis S., et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Rep. 2022;17:1089&#x2013;1104. doi: 10.1016/j.stemcr.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC9022216</ArticleId><ArticleId IdType="pubmed">35452595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicosia R.F., Ligresti G., Caporarello N., Akilesh S., Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am. J. Pathol. 2021;191:1374&#x2013;1384. doi: 10.1016/j.ajpath.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8141344</ArticleId><ArticleId IdType="pubmed">34033751</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom J.A. Monitoring of Respiration and Circulation. CRC Press; Boca Raton, FL, USA: 2003. p. 27.</Citation></Reference><Reference><Citation>Guest M.M., Bond T.P., Cooper R.G., Derrick J.R. Red Blood Cells: Change in Shape in Capillaries. Science. 1963;142:1319&#x2013;1321. doi: 10.1126/science.142.3597.1319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.142.3597.1319</ArticleId><ArticleId IdType="pubmed">14074848</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C., Sexton T., Smyth S.S. Translational Implications of Platelets as Vascular First Responders. Circ. Res. 2018;122:506&#x2013;522. doi: 10.1161/CIRCRESAHA.117.310939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310939</ArticleId><ArticleId IdType="pmc">PMC5808568</ArticleId><ArticleId IdType="pubmed">29420211</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan J.M., Gonagle D.M., Ward S.E., Preston R.J.S., O&#x2019;Donnell J.S. Endothelial cells orchestrate COVID-19 coagulopathy. Lancet Haematol. 2020;7:e553&#x2013;e555. doi: 10.1016/S2352-3026(20)30215-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30215-5</ArticleId><ArticleId IdType="pmc">PMC7326442</ArticleId><ArticleId IdType="pubmed">32619412</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z.W., van Wijk X.M.R., Pham H.P., Marin M.J. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J. Appl. Lab. Med. 2021;6:1305&#x2013;1315. doi: 10.1093/jalm/jfab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jalm/jfab042</ArticleId><ArticleId IdType="pmc">PMC8135722</ArticleId><ArticleId IdType="pubmed">33930144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker W.C., Brunius U., Gelin L.-E. Hemodynamic and microcirculatory effects of high and low viscosity dextrans. Surgery. 1965;58:518&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">14338545</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalker A.L. Histological changes produced by experimental erythrocyte aggregation. J. Pathol. Bacteriol. 1967;93:203&#x2013;212. doi: 10.1002/path.1700930120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1700930120</ArticleId><ArticleId IdType="pubmed">6029760</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalker A.L. The microcirculatory effects of dextran. J. Pathol. Bacteriol. 1967;93:191&#x2013;201. doi: 10.1002/path.1700930119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1700930119</ArticleId><ArticleId IdType="pubmed">6029757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajers C.M., Gelin L.E. Kidney-, liver- and heart-damages from trauma and from induced intravascular aggregation of blood-cells: An experimental study. Acta Pathol. Microbiol. Scand. 1959;46:97&#x2013;104. doi: 10.1111/j.1699-0463.1959.tb00322.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1699-0463.1959.tb00322.x</ArticleId><ArticleId IdType="pubmed">13821368</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank R.L., Fellman J.H., Hissen W.W. Aggregation of Blood Cells by 5-Hydroxytryptamine (Serotonin) Circ. Res. 1963;13:392&#x2013;400. doi: 10.1161/01.RES.13.5.392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.13.5.392</ArticleId><ArticleId IdType="pubmed">14077302</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen C.F., Swank R.L. Intravascular Aggregation and Adhesiveness of the Blood Elements Associated with Alimentary Lipemia and Injections of Large Molecular Substances. Circulation. 1954;9:335&#x2013;346. doi: 10.1161/01.CIR.9.3.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.9.3.335</ArticleId><ArticleId IdType="pubmed">13141361</ArticleId></ArticleIdList></Reference><Reference><Citation>Pribush A., Zilberman-Kravits D., Meyerstein N. The mechanism of the dextran-induced red blood cell aggregation. Eur. Biophys. J. 2007;36:85&#x2013;94. doi: 10.1007/s00249-006-0107-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-006-0107-1</ArticleId><ArticleId IdType="pubmed">17091267</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Avsievich T., Bykov A., Popov A., Meglinski I. Influence of Pulsed He&#x2013;Ne Laser Irradiation on the Red Blood Cell Interaction Studied by Optical Tweezers. Micromachines. 2019;10:853. doi: 10.3390/mi10120853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mi10120853</ArticleId><ArticleId IdType="pmc">PMC6953084</ArticleId><ArticleId IdType="pubmed">31817490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K., Shirshin E., Rovnyagina N., Yaya F., Boujja Z., Priezzhev A., Wagner C. Dextran adsorption onto red blood cells revisited: Single cell quantification by laser tweezers combined with microfluidics. Biomed. Opt. Express. 2018;9:2755&#x2013;2764. doi: 10.1364/BOE.9.002755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1364/BOE.9.002755</ArticleId><ArticleId IdType="pmc">PMC6154185</ArticleId><ArticleId IdType="pubmed">30258688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien S., Jan K.-m. Ultrastructural basis of the mechanism of rouleaux formation. Microvasc. Res. 1973;5:155&#x2013;166. doi: 10.1016/0026-2862(73)90068-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(73)90068-X</ArticleId><ArticleId IdType="pubmed">4694282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen Z.-Y., Guo Y.-C., Zhang Z.-G., Liang Y., Ge P.-J., Jin H.-M. Experimental Study on Microthrombi and Myocardial Injuries. Microvasc. Res. 1996;51:99&#x2013;107. doi: 10.1006/mvre.1996.0010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mvre.1996.0010</ArticleId><ArticleId IdType="pubmed">8812763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicher H.I. Blood Cell Aggregation in Thrombotic Processes. C. C. Thomas; Springfield, IL, USA: 1972. Chapter II: Pathological significance of intravascular red cell aggregation; pp. 19&#x2013;46.</Citation></Reference><Reference><Citation>Br&#xe5;nemark P.-I. Experimental Investigation of Microcirculation in Bone Marrow. Angiology. 1961;12:293&#x2013;305. doi: 10.1177/000331976101200705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331976101200705</ArticleId></ArticleIdList></Reference><Reference><Citation>Engeset J., Stalker A.L., Matheson N.A. Effects of Dextran 40 on Red Cell Aggregation in Rabbits. Cardiovasc. Res. 1967;1:379&#x2013;384. doi: 10.1093/cvr/1.4.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/1.4.379</ArticleId><ArticleId IdType="pubmed">6066342</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank R.L., Cullen C.F. Circulatory Changes in the Hamster&#x2019;s Cheek Pouch Associated with Alimentary Lipemia. Proc. Soc. Exp. Biol. Med. 1953;82:381&#x2013;384. doi: 10.3181/00379727-82-20123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-82-20123</ArticleId><ArticleId IdType="pubmed">13047408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjoerk V.O., Intonti F., Nordlund S. Correlation between sludge in the bulbar conjunctiva and the mesentery. Ann. Surg. 1964;159:428&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1408569</ArticleId><ArticleId IdType="pubmed">14129392</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinke W., Gaehtgens P., Johnson P.C. Blood viscosity in small tubes: Effect of shear rate, aggregation, and sedimentation. Am. J. Physiol.-Heart Circ. Physiol. 1987;253:H540&#x2013;H547. doi: 10.1152/ajpheart.1987.253.3.H540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1987.253.3.H540</ArticleId><ArticleId IdType="pubmed">3631291</ArticleId></ArticleIdList></Reference><Reference><Citation>Volger E., Schmid-Sch&#xf6;nbein H., Gosen J.v., Klose H.J., Kline K.A. Microrheology and light transmission of blood. Pfl&#xfc;gers Arch. 1975;354:319&#x2013;337. doi: 10.1007/BF00587850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00587850</ArticleId><ArticleId IdType="pubmed">1167684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosek M., Ziomkowska B., Pyskir J., Wybranowski T., Pyskir M., Cyrankiewicz M., Napi&#xf3;rkowska M., Durmowicz M., Kruszewski S. Relationship between red blood cell aggregation and dextran molecular mass. Sci. Rep. 2022;12:19751. doi: 10.1038/s41598-022-24166-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24166-w</ArticleId><ArticleId IdType="pmc">PMC9670059</ArticleId><ArticleId IdType="pubmed">36396711</ArticleId></ArticleIdList></Reference><Reference><Citation>Neu B., Wenby R., Meiselman H.J. Effects of dextran molecular weight on red blood cell aggregation. Biophys. J. 2008;95:3059&#x2013;3065. doi: 10.1529/biophysj.108.130328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.108.130328</ArticleId><ArticleId IdType="pmc">PMC2527284</ArticleId><ArticleId IdType="pubmed">18586848</ArticleId></ArticleIdList></Reference><Reference><Citation>Engeset J., Stalker A.L., Matheson N.A. Objective measurement of the dispersing effect of dextran 40 on red cells from man, dog, and rabbit. Cardiovasc. Res. 1967;1:385&#x2013;388. doi: 10.1093/cvr/1.4.385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/1.4.385</ArticleId><ArticleId IdType="pubmed">6066343</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskurt O.K., Meiselman H.J. Erythrocyte aggregation: Basic aspects and clinical importance. Clin. Hemorheol. Microcirc. 2013;53:23&#x2013;37. doi: 10.3233/CH-2012-1573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-2012-1573</ArticleId><ArticleId IdType="pubmed">22975932</ArticleId></ArticleIdList></Reference><Reference><Citation>Barshtein G., Wajnblum D., Yedgar S. Kinetics of linear rouleaux formation studied by visual monitoring of red cell dynamic organization. Biophys. J. 2000;78:2470&#x2013;2474. doi: 10.1016/S0006-3495(00)76791-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(00)76791-9</ArticleId><ArticleId IdType="pmc">PMC1300836</ArticleId><ArticleId IdType="pubmed">10777743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung Y.-C. Biomechanics: Mechanical Properties of Living Tissues. Springer; New York, NY, USA: 1993. Chapter 3: The flow properties of blood; pp. 66&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4757-2257-4_3</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicher H.I. Blood Cell Aggregation in Thrombotic Processes. Volume I. C. C. Thomas; Springfield, IL, USA: 1972. Chapter I: Red cell aggregation in thrombotic disease, trauma and shock; pp. 5&#x2013;18.</Citation></Reference><Reference><Citation>Bicher H.I. Blood Cell Aggregation in Thrombotic Processes. Volume III. C. C. Thomas; Springfield, IL, USA: 1972. Chapter III: Mechanism of red cell aggregation; pp. 47&#x2013;61.</Citation></Reference><Reference><Citation>Brooks D.E., Evans E.A. Rheology of blood cells. In: Chien S., Dormandy J., Ernst E., Matrai A., editors. Clinical Hemorheology: Applications in Cardiovascular and Hematological Disease, Diabetes, Surgery and Gynecology. Springer; Dordrecht, The Netherlands: 1987. pp. 73&#x2013;96.</Citation></Reference><Reference><Citation>Lowe G.D.O. Thrombosis and hemorheology. In: Chien S., Dormandy J., Ernst E., Matrai A., editors. Clinical Hemorheology: Applications in Cardiovascular and Hematological Disease, Diabetes, Surgery and Gynecology. Springer; Dordrecht, The Netherlands: 1987. pp. 195&#x2013;226.</Citation></Reference><Reference><Citation>Bishop J.J., Nance P.R., Popel A.S., Intaglietta M., Johnson P.C. Effect of erythrocyte aggregation on velocity profiles in venules. Am. J. Physiol.-Heart Circ. Physiol. 2001;280:H222&#x2013;H236. doi: 10.1152/ajpheart.2001.280.1.H222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2001.280.1.H222</ArticleId><ArticleId IdType="pubmed">11123237</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien S., Sung L.A. Physicochemical basis and clinical implications of red cell aggregation. Clin. Hemorheol. Microcirc. 1987;7:71&#x2013;91. doi: 10.3233/CH-1987-7108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-1987-7108</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda N., Seike M., Kon K., Shiga T. Erythrocyte Aggregation as a Determinant of Blood Flow: Effect of pH, Temperature and Osmotic Pressure. In: Mochizuki M., Honig C.R., Koyama T., Goldstick T.K., Bruley D.F., editors. Oxygen Transport to Tissue X. Springer US; New York, NY, USA: 1988. pp. 563&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">3364282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakariassen K.S., Orning L., Turitto V.T. The impact of blood shear rate on arterial thrombus formation. Future Sci. OA. 2015;1:FSO30. doi: 10.4155/fso.15.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fso.15.28</ArticleId><ArticleId IdType="pmc">PMC5137878</ArticleId><ArticleId IdType="pubmed">28031903</ArticleId></ArticleIdList></Reference><Reference><Citation>Knisely M.H., Bloch E.H., Eliot T.S., Warner L. Sludged Blood. Science. 1947;106:431&#x2013;440. doi: 10.1126/science.106.2758.431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.106.2758.431</ArticleId><ArticleId IdType="pubmed">17781897</ArticleId></ArticleIdList></Reference><Reference><Citation>Barshtein G., Ben-Ami R., Yedgar S. Role of red blood cell flow behavior in hemodynamics and hemostasis. Expert Rev. Cardiovasc. Ther. 2007;5:743&#x2013;752. doi: 10.1586/14779072.5.4.743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14779072.5.4.743</ArticleId><ArticleId IdType="pubmed">17605652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditzel J., Sagild U. Morphologic and hemodynamic changes in the smaller blood vessels in diabetes mellitus. II. The degenerative and hemodynamic changes in the bulbar conjunctiva of normotensive diabetic patients. N. Engl. J. Med. 1954;250:587&#x2013;594. doi: 10.1056/NEJM195404082501401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM195404082501401</ArticleId><ArticleId IdType="pubmed">13154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon Jeffords J., Knisely M.H. Concerning the Geometric Shapes of Arteries and Arterioles: A Contribution to the Biophysics of Health, Disease, and Death. Angiology. 1956;7:105&#x2013;136. doi: 10.1177/000331975600700202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331975600700202</ArticleId><ArticleId IdType="pubmed">13314150</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F.T., Armstrong J.K., Tripette J., Meiselman H.J., Cloutier G. A local increase in red blood cell aggregation can trigger deep vein thrombosis: Evidence based on quantitative cellular ultrasound imaging. J. Thromb. Haemost. 2011;9:481&#x2013;488. doi: 10.1111/j.1538-7836.2010.04164.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.04164.x</ArticleId><ArticleId IdType="pmc">PMC3050084</ArticleId><ArticleId IdType="pubmed">21143377</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes J.R., Wolberg A.S. Red blood cells in thrombosis. Blood. 2017;130:1795&#x2013;1799. doi: 10.1182/blood-2017-03-745349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-03-745349</ArticleId><ArticleId IdType="pmc">PMC5649548</ArticleId><ArticleId IdType="pubmed">28811305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ami R.B., Barshtein G., Zeltser D., Goldberg Y., Shapira I., Roth A., Keren G., Miller H., Prochorov V., Eldor A., et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am. J. Physiol.-Heart Circ. Physiol. 2001;280:H1982&#x2013;H1988. doi: 10.1152/ajpheart.2001.280.5.H1982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2001.280.5.H1982</ArticleId><ArticleId IdType="pubmed">11299197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Steffen P., Svetina S. Aggregation of red blood cells: From rouleaux to clot formation. C. R. Phys. 2013;14:459&#x2013;469. doi: 10.1016/j.crhy.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crhy.2013.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiselman H.J. Red blood cell aggregation: 45 years being curious. Biorheology. 2009;46:1&#x2013;19. doi: 10.3233/BIR-2009-0522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BIR-2009-0522</ArticleId><ArticleId IdType="pubmed">19252224</ArticleId></ArticleIdList></Reference><Reference><Citation>Junxiu Z., Yu F., Shaodan L., Yi L., Yin Z., Yunxia G., Minghui Y. Microvascular pathological features and changes in related injury factors in a rat acute blood stasis model. J. Tradit. Chin. Med. 2017;37:108&#x2013;115. doi: 10.1016/S0254-6272(17)30034-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0254-6272(17)30034-1</ArticleId><ArticleId IdType="pubmed">29957919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Popel A.S., Intaglietta M., Johnson P.C. Aggregate formation of erythrocytes in postcapillary venules. Am. J. Physiol.-Heart Circ. Physiol. 2005;288:H584&#x2013;H590. doi: 10.1152/ajpheart.00690.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00690.2004</ArticleId><ArticleId IdType="pubmed">15458951</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank R.L. Suspension Stability of the Blood After Injections of Dextran. J. Appl. Physiol. 1958;12:125&#x2013;128. doi: 10.1152/jappl.1958.12.1.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1958.12.1.125</ArticleId><ArticleId IdType="pubmed">13502270</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank R.L., Escobar A. Effects of Dextran Injections on Blood Viscosity in Dogs. J. Appl. Physiol. 1957;10:45&#x2013;50. doi: 10.1152/jappl.1957.10.1.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1957.10.1.45</ArticleId><ArticleId IdType="pubmed">13405828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicher H.I., Bruley D., Knisely M.H., Reneau D.D. Effect of microcirculation changes on brain tissue oxygenation. J. Physiol. 1971;217:689&#x2013;707. doi: 10.1113/jphysiol.1971.sp009594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1971.sp009594</ArticleId><ArticleId IdType="pmc">PMC1331571</ArticleId><ArticleId IdType="pubmed">5098086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hysi E., Saha R.K., Kolios M.C. Photoacoustic ultrasound spectroscopy for assessing red blood cell aggregation and oxygenation. J. Biomed. Opt. 2012;17:125006. doi: 10.1117/1.JBO.17.12.125006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.17.12.125006</ArticleId><ArticleId IdType="pubmed">23235833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditzel J. Angioscopic Changes in the Smaller Blood Vessels in Diabetes Mellitus and their Relationship to Aging. Circulation. 1956;14:386&#x2013;397. doi: 10.1161/01.CIR.14.3.386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.14.3.386</ArticleId><ArticleId IdType="pubmed">13365051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler O., Guerci B., Muller S., Candiloros H., Mejean L., Donner M., Stoltz J.F., Drouin P. Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: A multivariate analysis. Metabolism. 1994;43:1182&#x2013;1186. doi: 10.1016/0026-0495(94)90063-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-0495(94)90063-9</ArticleId><ArticleId IdType="pubmed">8084293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazan B.I. Intravascular Red Cell Aggregation and the Chylomicron Count in Diabetes. Angiology. 1963;14:426&#x2013;429. doi: 10.1177/000331976301400807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331976301400807</ArticleId><ArticleId IdType="pubmed">14059281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.I., Mooney M.P., Cho D.J. Hemorheological Disorders in Diabetes Mellitus. J. Diabetes Sci. Technol. 2008;2:1130&#x2013;1138. doi: 10.1177/193229680800200622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229680800200622</ArticleId><ArticleId IdType="pmc">PMC2769810</ArticleId><ArticleId IdType="pubmed">19885302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wautier J.L., Paton R.C., Wautier M.P., Pintigny D., Abadie E., Passa P., Caen J.P. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N. Engl. J. Med. 1981;305:237&#x2013;242. doi: 10.1056/NEJM198107303050501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198107303050501</ArticleId><ArticleId IdType="pubmed">7242613</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami T., Miyashita H., Yamada T., Harrington M., Steinberg D., Dunn A., Siau E. Risk Factors for Mortality in Patients with COVID-19 in New York City. J. Gen. Intern. Med. 2020;36:17&#x2013;26. doi: 10.1007/s11606-020-05983-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05983-z</ArticleId><ArticleId IdType="pmc">PMC7325642</ArticleId><ArticleId IdType="pubmed">32607928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry S., Cuomo F., Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thromb. Res. 2022;212:51&#x2013;57. doi: 10.1016/j.thromres.2022.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.02.016</ArticleId><ArticleId IdType="pmc">PMC8864963</ArticleId><ArticleId IdType="pubmed">35219932</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila J., Long B., Holladay D., Gottlieb M. Thrombotic complications of COVID-19. Am. J. Emerg. Med. 2021;39:213&#x2013;218. doi: 10.1016/j.ajem.2020.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.09.065</ArticleId><ArticleId IdType="pmc">PMC7528743</ArticleId><ArticleId IdType="pubmed">33036855</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Karp Leaf R.S., Dzik W.H., Carlson J.C.T., Fogerty A.E., Waheed A., Goodarzi K., Bendapudi P.K., Bornikova L., Gupta S., et al. COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489&#x2013;500. doi: 10.1182/blood.2020006520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M., Duarte-Neto A.N., de Almeida Monteiro R.A., da Silva L.F.F., de Oliveira E.P., Saldiva P.H.N., Mauad T., Negri E.M. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J. Thromb. Haemost. 2020;18:1517&#x2013;1519. doi: 10.1111/jth.14844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14844</ArticleId><ArticleId IdType="pmc">PMC7262093</ArticleId><ArticleId IdType="pubmed">32294295</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C.L., Truong A.D., Auld S.C., Polly D.M., Tanksley C.-L., Duncan A. COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia? Lancet. 2020;395:1758&#x2013;1759. doi: 10.1016/S0140-6736(20)31209-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31209-5</ArticleId><ArticleId IdType="pmc">PMC7247793</ArticleId><ArticleId IdType="pubmed">32464112</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A., Osiaevi I., Buscher K., Sackarnd J., Tepasse P.-R., Fobker M., K&#xfc;hn J., Braune S., G&#xf6;bel U., Th&#xf6;lking G., et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis. 2021;24:145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>US National Institutes of Health (NIH)  Clinical Spectrum of SARS-CoV-2 Infection, Updated 6 March 2023.  [(accessed on 30 October 2023)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., K&#xfc;mpers P., Mohr M., Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lins M., Vandevenne J., Thillai M., Lavon B.R., Lanclus M., Bonte S., Godon R., Kendall I., De Backer J., De Backer W. Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT. Acad. Radiol. 2020;27:1449&#x2013;1455. doi: 10.1016/j.acra.2020.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.07.019</ArticleId><ArticleId IdType="pmc">PMC7381940</ArticleId><ArticleId IdType="pubmed">32741657</ArticleId></ArticleIdList></Reference><Reference><Citation>Thillai M., Patvardhan C., Swietlik E.M., McLellan T., De Backer J., Lanclus M., De Backer W., Ruggiero A. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19. Thorax. 2021;76:182&#x2013;184. doi: 10.1136/thoraxjnl-2020-215395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215395</ArticleId><ArticleId IdType="pubmed">32859733</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.F., Pershad Y., Kang P., Ridenour L., Lavon B., Lanclus M., Godon R., De Backer J., Glassberg M.K. Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease. Eur. Respir. J. 2021;58:2004133. doi: 10.1183/13993003.04133-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04133-2020</ArticleId><ArticleId IdType="pmc">PMC7908189</ArticleId><ArticleId IdType="pubmed">33632795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dierckx W., De Backer W., Lins M., De Meyer Y., Ides K., Vandevenne J., De Backer J., Franck E., Lavon B.R., Lanclus M., et al. CT-derived measurements of pulmonary blood volume in small vessels and the need for supplemental oxygen in COVID-19 patients. J. Appl. Physiol. (1985) 2022;133:1295&#x2013;1299. doi: 10.1152/japplphysiol.00458.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00458.2022</ArticleId><ArticleId IdType="pmc">PMC9722246</ArticleId><ArticleId IdType="pubmed">36269576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipre D.N., Cidon M., Moats R.A. Imaging Pulmonary Blood Vessels and Ventilation-Perfusion Mismatch in COVID-19. Mol. Imaging Biol. 2022;24:526&#x2013;536. doi: 10.1007/s11307-021-01700-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-021-01700-2</ArticleId><ArticleId IdType="pmc">PMC8764889</ArticleId><ArticleId IdType="pubmed">35041149</ArticleId></ArticleIdList></Reference><Reference><Citation>Atilgan C.U., Goker Y.S., Hondur G., Kosekahya P., Kocer A.M., Citirik M. Evaluation of the radial peripapillary capillary density in unilateral branch retinal vein occlusion and the unaffected fellow eyes. Ther. Adv. Ophthalmol. 2022;14 doi: 10.1177/25158414221090092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25158414221090092</ArticleId><ArticleId IdType="pmc">PMC9019368</ArticleId><ArticleId IdType="pubmed">35464343</ArticleId></ArticleIdList></Reference><Reference><Citation>Erogul O., Gobeka H.H., Dogan M., Akdogan M., Balci A., Kasikci M. Retinal microvascular morphology versus COVID-19: What to anticipate? Photodiagn. Photodyn. Ther. 2022;39:102920. doi: 10.1016/j.pdpdt.2022.102920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.102920</ArticleId><ArticleId IdType="pmc">PMC9116963</ArticleId><ArticleId IdType="pubmed">35597442</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A., Crincoli E., Savastano M.C., Younis S., Gambini G., De Vico U., Cozzupoli G.M., Culiersi C., Rizzo S. Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J. Clin. Med. 2020;9:2895. doi: 10.3390/jcm9092895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092895</ArticleId><ArticleId IdType="pmc">PMC7565672</ArticleId><ArticleId IdType="pubmed">32911619</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlick S., Lucio M., Wallukat G., Bartsch A., Skornia A., Hoffmanns J., Szewczykowski C., Schr&#xf6;der T., Raith F., Rogge L., et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022;23:13683. doi: 10.3390/ijms232213683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="pubmed">36430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R., Ai S., Cai J., Zhang S., Qian Z.M., Zhang Y., Wu Y., Chen L., Tian F., Li H., et al. Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China. Innovation. 2020;1:100022. doi: 10.1016/j.xinn.2020.100022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2020.100022</ArticleId><ArticleId IdType="pmc">PMC7832941</ArticleId><ArticleId IdType="pubmed">33521759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., Curtis H.J., Mehrkar A., Evans D., Inglesby P., et al. OpenSAFELY: Factors associated with COVID-19 death in 17 million patients. Nature. 2020;584:430&#x2013;436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanad C., Garc&#xed;a-Blas S., Tarazona-Santabalbina F., Sanchis J., Bertomeu-Gonz&#xe1;lez V., F&#xe1;cila L., Ariza A., N&#xfa;&#xf1;ez J., Cordero A. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. J. Am. Med. Dir. Assoc. 2020;21:915&#x2013;918. doi: 10.1016/j.jamda.2020.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.05.045</ArticleId><ArticleId IdType="pmc">PMC7247470</ArticleId><ArticleId IdType="pubmed">32674819</ArticleId></ArticleIdList></Reference><Reference><Citation>Manetta J., Aloulou I., Varlet-Marie E., Mercier J., Brun J.F. Partially opposite hemorheological effects of aging and training at middle age. Clin. Hemorheol. Microcirc. 2006;35:239&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">16899935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammi H., Perrotin P., Guillet R., Boynard M. Determination of red blood cell aggregation in young and elderly subjects evaluated by ultrasound. Clin. Hemorheol. Microcirc. 1994;14:117&#x2013;126. doi: 10.3233/CH-1994-14115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-1994-14115</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson D., Schwartz R. Comparison of capillary blood flow in the nailfold circulations of young and elderly men. AGE. 1985;8:70. doi: 10.1007/BF02432074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02432074</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson D., Shepherd S. The cutaneous microcirculation of the forearm in young and old subjects. Microvasc. Res. 1991;41:84&#x2013;91. doi: 10.1016/0026-2862(91)90010-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(91)90010-9</ArticleId><ArticleId IdType="pubmed">2051956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida Y. The effect of aging and arteriosclerosis on human skin blood flow. J. Dermatol. Sci. 1993;5:175&#x2013;181. doi: 10.1016/0923-1811(93)90764-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0923-1811(93)90764-G</ArticleId><ArticleId IdType="pubmed">8241073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmani R.S., Rifkind J.M. Hemorheological changes during human aging. Gerontology. 1998;44:111&#x2013;120. doi: 10.1159/000021993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000021993</ArticleId><ArticleId IdType="pubmed">9523223</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinenno F.A., Jones P.P., Seals D.R., Tanaka H. Limb Blood Flow and Vascular Conductance Are Reduced With Age in Healthy Humans. Circulation. 1999;100:164&#x2013;170. doi: 10.1161/01.CIR.100.2.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.100.2.164</ArticleId><ArticleId IdType="pubmed">10402446</ArticleId></ArticleIdList></Reference><Reference><Citation>Krejza J., Mariak Z., Walecki J., Szydlik P., Lewko J., Ustymowicz A. Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: Age and sex variability and normal reference values for blood flow parameters. AJR Am. J. Roentgenol. 1999;172:213&#x2013;218. doi: 10.2214/ajr.172.1.9888770.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.172.1.9888770</ArticleId><ArticleId IdType="pubmed">9888770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerstaff R.G.A., Keunen R.W.M., Pelt W.v., Swijndregt A.D.M.v., Stijnen T. Influence of biological factors on changes in mean cerebral blood flow velocity in normal ageing: A transcranial Doppler study. Neurol. Res. 1990;12:187&#x2013;191. doi: 10.1080/01616412.1990.11739941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.1990.11739941</ArticleId><ArticleId IdType="pubmed">1979850</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison S.L., Buckley B.J.R., Rivera-Caravaca J.M., Zhang J., Lip G.Y.H. Cardiovascular risk factors, cardiovascular disease, and COVID-19: An umbrella review of systematic reviews. Eur. Heart J.-Qual. Care Clin. Outcomes. 2021;7:330&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294691</ArticleId><ArticleId IdType="pubmed">34107535</ArticleId></ArticleIdList></Reference><Reference><Citation>Samocha-Bonet D., Ben-Ami R., Shapira I., Shenkerman G., Abu-Abeid S., Stern N., Mardi T., Tulchinski T., Deutsch V., Yedgar S., et al. Flow-resistant red blood cell aggregation in morbid obesity. Int. J. Obes. 2004;28:1528&#x2013;1534. doi: 10.1038/sj.ijo.0802791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ijo.0802791</ArticleId><ArticleId IdType="pubmed">15467777</ArticleId></ArticleIdList></Reference><Reference><Citation>Samocha-Bonet D., Lichtenberg D., Tomer A., Deutsch V., Mardi T., Goldin Y., Abu-Abeid S., Shenkerman G., Patshornik H., Shapira I., et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. Obes. Res. 2003;11:403&#x2013;407. doi: 10.1038/oby.2003.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2003.54</ArticleId><ArticleId IdType="pubmed">12634437</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Farf&#xe1;n D., Irigoyen N., G&#xf3;mez-D&#xed;az E. Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes. Front. Immunol. 2023;14:1120298. doi: 10.3389/fimmu.2023.1120298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1120298</ArticleId><ArticleId IdType="pmc">PMC10041564</ArticleId><ArticleId IdType="pubmed">36993979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bicher H.I., Beemer A.M. Induction of ischemic myocardial damage by red blood cell aggregation (sludge) in the rabbit. J. Atheroscler Res. 1967;7:409&#x2013;414. doi: 10.1016/S0368-1319(67)80019-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0368-1319(67)80019-X</ArticleId><ArticleId IdType="pubmed">6058198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M., Kase M., Sano H., Kamijima R., Sano S. Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion. J. Cutan. Immunol. Allergy. 2023;6:18&#x2013;23. doi: 10.1002/cia2.12278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cia2.12278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano H., Kase M., Aoyama Y., Sano S. A case of persistent, confluent maculopapular erythema following a COVID-19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis. J. Dermatol. 2023;50:1208&#x2013;1212. doi: 10.1111/1346-8138.16816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.16816</ArticleId><ArticleId IdType="pubmed">37154426</ArticleId></ArticleIdList></Reference><Reference><Citation>Morz M. A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19. Vaccines. 2022;10:1651. doi: 10.3390/vaccines10101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101651</ArticleId><ArticleId IdType="pmc">PMC9611676</ArticleId><ArticleId IdType="pubmed">36298516</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Chen Y., Zhao Y., Lung D.C., Ye Z., Song W., Liu F.-F., Cai J.-P., Wong W.-M., Yip C.C.-Y., et al. Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clin. Infect. Dis. 2022;74:1933&#x2013;1950. doi: 10.1093/cid/ciab707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab707</ArticleId><ArticleId IdType="pmc">PMC8436386</ArticleId><ArticleId IdType="pubmed">34406358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan G.M., Tarek M. COVID 19 m-RNA (Pfizer) vaccination impairs cardiac functions in adult male rats. Bull. Egypt. Soc. Physiol. Sci. 2023;43:211&#x2013;228. doi: 10.21608/besps.2023.213045.1144.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/besps.2023.213045.1144</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedik B., Bozdogan Y.C., Yavuz S., Durmaz D., Erol M.K. The assesment of retina and optic disc vascular structures in people who received CoronaVac vaccine. Photodiagn. Photodyn. Ther. 2022;38:102742. doi: 10.1016/j.pdpdt.2022.102742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.102742</ArticleId><ArticleId IdType="pmc">PMC8801730</ArticleId><ArticleId IdType="pubmed">35101623</ArticleId></ArticleIdList></Reference><Reference><Citation>Saritas O., Yorgun M.A., Gokpinar E. Effects of Sinovac-Coronavac and Pfizer-BioNTech mRNA vaccines on choroidal and retinal vascular system. Photodiagn. Photodyn. Ther. 2023;43:103702. doi: 10.1016/j.pdpdt.2023.103702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2023.103702</ArticleId><ArticleId IdType="pubmed">37429458</ArticleId></ArticleIdList></Reference><Reference><Citation>Gedik B., Erol M.K., Suren E., Yavuz S., Kucuk M.F., Bozdogan Y.C., Ekinci R., Akidan M. Evaluation of retinal and optic disc vascular structures in individuals before and after Pfizer-BioNTech vaccination. Microvasc. Res. 2023;147:104500. doi: 10.1016/j.mvr.2023.104500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2023.104500</ArticleId><ArticleId IdType="pubmed">36746365</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva L.S.C., Finamor L.P.S., Andrade G.C., Lima L.H., Zett C., Muccioli C., Sarraf E.P. Vascular retinal findings after COVID-19 vaccination in 11 cases: A coincidence or consequence? Arq. Bras. Oftalmol. 2022;85:158&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">35298583</ArticleId></ArticleIdList></Reference><Reference><Citation>Haseeb A.A., Solyman O., Abushanab M.M., Abo Obaia A.S., Elhusseiny A.M. Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective. Vaccines. 2022;10:342. doi: 10.3390/vaccines10020342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020342</ArticleId><ArticleId IdType="pmc">PMC8875181</ArticleId><ArticleId IdType="pubmed">35214800</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider A., Bengs S., Schade K., Wijnen W.J., Portmann A., Etter D., Fr&#xf6;hlich S., Warnock G.I., Treyer V., Burger I.A., et al. Myocardial 18F-FDG Uptake Pattern for Cardiovascular Risk Stratification in Patients Undergoing Oncologic PET/CT. J. Clin. Med. 2020;9:2279. doi: 10.3390/jcm9072279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9072279</ArticleId><ArticleId IdType="pmc">PMC7408629</ArticleId><ArticleId IdType="pubmed">32709049</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y., Li Y.-M., He Z.-X., Civelek A.C., Li X.-F. Likely Common Role of Hypoxia in Driving 18F-FDG Uptake in Cancer, Myocardial Ischemia, Inflammation and Infection. Cancer Biother. Radiopharm. 2021;36:624&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">34375126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahara T., Iwabuchi Y., Miyazawa R., Tonda K., Shiga T., Strauss H.W., Antoniades C., Narula J., Jinzaki M. Assessment of Myocardial (18)F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients. Radiology. 2023;308:e230743. doi: 10.1148/radiol.230743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.230743</ArticleId><ArticleId IdType="pubmed">37724969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundry S.R. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation. 2021;144:A10712. doi: 10.1161/circ.144.suppl_1.10712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.144.suppl_1.10712</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Centers for Disease Control and Prevention, Vaccines and Related Biological Products Advisory Committee (VRBPAC)  Update on Myocarditis following mRNA COVID-19 Vaccination.  [(accessed on 30 October 2023)];2022 June 7; Available online:  https://www.fda.gov/media/159007/download.</Citation></Reference><Reference><Citation>Truong D.T., Dionne A., Muniz J.C., McHugh K.E., Portman M.A., Lambert L.M., Thacker D., Elias M.D., Li J.S., Toro-Salazar O.H., et al. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults. Circulation. 2022;145:345&#x2013;356. doi: 10.1161/CIRCULATIONAHA.121.056583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056583</ArticleId><ArticleId IdType="pubmed">34865500</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu S.N., Chen Y.S., Hsu C.C., Hua Y.C., Tseng W.C., Lu C.W., Lin M.T., Chen C.A., Wu M.H., Chen Y.T., et al. Changes of ECG parameters after BNT162b2 vaccine in the senior high school students. Eur. J. Pediatr. 2023;182:1155&#x2013;1162. doi: 10.1007/s00431-022-04786-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04786-0</ArticleId><ArticleId IdType="pmc">PMC9813456</ArticleId><ArticleId IdType="pubmed">36602621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansanguan S., Charunwatthana P., Piyaphanee W., Dechkhajorn W., Poolcharoen A., Mansanguan C. Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Trop. Med. Infect. Dis. 2022;7:196. doi: 10.3390/tropicalmed7080196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7080196</ArticleId><ArticleId IdType="pmc">PMC9414075</ArticleId><ArticleId IdType="pubmed">36006288</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Swank Z., Bartsch Y.C., Burns M.D., Kane A., Boribong B.P., Davis J.P., Loiselle M., Novak T., Senussi Y., et al. Circulating Spike Protein Detected in Post&#x2013;COVID-19 mRNA Vaccine Myocarditis. Circulation. 2023;147:867&#x2013;876. doi: 10.1161/CIRCULATIONAHA.122.061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.061025</ArticleId><ArticleId IdType="pmc">PMC10010667</ArticleId><ArticleId IdType="pubmed">36597886</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauson A.J., Casimero F.V.C., Siddiquee Z., Stone J.R. Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients. NPJ Vaccines. 2023;8:141. doi: 10.1038/s41541-023-00742-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00742-7</ArticleId><ArticleId IdType="pmc">PMC10533894</ArticleId><ArticleId IdType="pubmed">37758751</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumeier C., Aleshcheva G., Harms D., Gross U., Hamm C., Assmus B., Westenfeld R., Kelm M., Rammos S., Wenzel P., et al. Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series. Int. J. Mol. Sci. 2022;23:6940. doi: 10.3390/ijms23136940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23136940</ArticleId><ArticleId IdType="pmc">PMC9266869</ArticleId><ArticleId IdType="pubmed">35805941</ArticleId></ArticleIdList></Reference><Reference><Citation>Negri E.M., Piloto B.M., Morinaga L.K., Jardim C.V.P., Lamy S.A.E.-D., Ferreira M.A., D&#x2019;Amico E.A., Deheinzelin D. Heparin Therapy Improving Hypoxia in COVID-19 Patients&#x2014;A Case Series. Front. Physiol. 2020;11:1341. doi: 10.3389/fphys.2020.573044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.573044</ArticleId><ArticleId IdType="pmc">PMC7604350</ArticleId><ArticleId IdType="pubmed">33192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibnhadjamor H., Jdidi J., Torjmen S., Kraiem S., Bahloul A., Makni A., Kallel N., Moussa N., Boudaya M., et al. Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Prominent Researchers Look Deeper into Fluvoxamine and See Potential as COVID-19 Treatment. Trialsite News. Apr 25, 2021.  [(accessed on 30 October 2023)].  Available online:  https://trialsitenews.com/prominent-researchers-look-deeper-into-fluvoxamine-see-potential-as-covid-19-treatment/</Citation></Reference><Reference><Citation>Johnson C.K. Cheap Antidepressant Shows Promise Treating Early COVID-19. Yahoo News. Oct 27, 2021.  [(accessed on 30 October 2023)].  Available online:  http://News.yahoo.com/cheap-antidepressant-shows-promise-treating-223735055.html.</Citation></Reference><Reference><Citation>Sukhatme V.P., Reiersen A.M., Vayttaden S.J., Sukhatme V.V. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19. Front. Pharmacol. 2021;12:763. doi: 10.3389/fphar.2021.652688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.652688</ArticleId><ArticleId IdType="pmc">PMC8094534</ArticleId><ArticleId IdType="pubmed">33959018</ArticleId></ArticleIdList></Reference><Reference><Citation>Seftel D., Boulware D.R. Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19. Open Forum Infect. Dis. 2021;8:ofab050. doi: 10.1093/ofid/ofab050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab050</ArticleId><ArticleId IdType="pmc">PMC7888564</ArticleId><ArticleId IdType="pubmed">33623808</ArticleId></ArticleIdList></Reference><Reference><Citation>Facente S.N., Reiersen A.M., Lenze E.J., Boulware D.R., Klausner J.D. Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs. 2021;81:2081&#x2013;2089. doi: 10.1007/s40265-021-01636-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-021-01636-5</ArticleId><ArticleId IdType="pmc">PMC8633915</ArticleId><ArticleId IdType="pubmed">34851510</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G., Moreira Silva E.A., Medeiros Silva D.C., Thabane L., Milagres A.C., Ferreira T.S., dos Santos C.V.Q., de Souza Campos V.H., Nogueira A.M.R., de Almeida A.P.F.G., et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: The TOGETHER randomised, platform clinical trial. Lancet Glob. Health. 2022;10:e42&#x2013;e51. doi: 10.1016/S2214-109X(21)00448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00448-4</ArticleId><ArticleId IdType="pmc">PMC8550952</ArticleId><ArticleId IdType="pubmed">34717820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze E.J., Mattar C., Zorumski C.F., Stevens A., Schweiger J., Nicol G.E., Miller J.P., Yang L., Yingling M., Avidan M.S., et al. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020;324:2292&#x2013;2300. doi: 10.1001/jama.2020.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22760</ArticleId><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank R.L., Edwards M.J. Microvascular occlusion by platelet emboli after transfusion and shock. Microvasc. Res. 1968;1:15&#x2013;22. doi: 10.1016/0026-2862(68)90003-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(68)90003-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez J.C., Gluck N., Fallet A., Gr&#xe9;goire A., Chevalier J.F., Advenier C., Spreux-Varoquaux O. Plasma serotonin level after 1 day of fluoxetine treatment: A biological predictor for antidepressant response? Psychopharmacology. 1999;143:97&#x2013;101. doi: 10.1007/s002130050924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002130050924</ArticleId><ArticleId IdType="pubmed">10227085</ArticleId></ArticleIdList></Reference><Reference><Citation>Celada P., Dolera M., Alvarez E., Artigas F. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J. Affect. Disord. 1992;25:243&#x2013;249. doi: 10.1016/0165-0327(92)90082-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0327(92)90082-H</ArticleId><ArticleId IdType="pubmed">1385505</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerschmied D., Suidan G.L., Demers M., Herr N., Carbo C., Brill A., Cifuni S.M., Mauler M., Cicko S., Bader M., et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. 2013;121:1008&#x2013;1015. doi: 10.1182/blood-2012-06-437392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-06-437392</ArticleId><ArticleId IdType="pmc">PMC3567335</ArticleId><ArticleId IdType="pubmed">23243271</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M., Neavin D., Liu D., Biernacka J., Hall-Flavin D., Bobo W.V., Frye M.A., Skime M., Jenkins G.D., Batzler A., et al. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: Pharmacometabolomics-informed pharmacogenomics. Mol. Psychiatry. 2016;21:1717&#x2013;1725. doi: 10.1038/mp.2016.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.6</ArticleId><ArticleId IdType="pmc">PMC5003027</ArticleId><ArticleId IdType="pubmed">26903268</ArticleId></ArticleIdList></Reference><Reference><Citation>Holck A., Wolkowitz O.M., Mellon S.H., Reus V.I., Nelson J.C., Westrin &#xc5;., Lindqvist D. Plasma serotonin levels are associated with antidepressant response to SSRIs. J. Affect. Disord. 2019;250:65&#x2013;70. doi: 10.1016/j.jad.2019.02.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2019.02.063</ArticleId><ArticleId IdType="pmc">PMC6699768</ArticleId><ArticleId IdType="pubmed">30831543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristjansdottir H.L., Lewerin C., Lerner U.H., Waern E., Johansson H., Sundh D., Karlsson M., Cummings S.R., Zetterberg H., Lorentzon M., et al. High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study. J. Bone Miner. Res. 2018;33:1560&#x2013;1567. doi: 10.1002/jbmr.3443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.3443</ArticleId><ArticleId IdType="pubmed">29750841</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbina M., Pineda S., Pi&#xf1;ango L., Carreira I., Lima L. [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int. J. Immunopharmacol. 1999;21:631&#x2013;646. doi: 10.1016/S0192-0561(99)00035-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0192-0561(99)00035-1</ArticleId><ArticleId IdType="pubmed">12609459</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro A.M., Cook E.H., Murphy D.L., Blakely R.D. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J. Clin. Investig. 2008;118:1544&#x2013;1552. doi: 10.1172/JCI33374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI33374</ArticleId><ArticleId IdType="pmc">PMC2260909</ArticleId><ArticleId IdType="pubmed">18317590</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloskey D.J., Postolache T.T., Vittone B.J., Nghiem K.L., Monsale J.L., Wesley R.A., Rick M.E. Selective serotonin reuptake inhibitors: Measurement of effect on platelet function. Transl. Res. 2008;151:168&#x2013;172. doi: 10.1016/j.trsl.2007.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2007.10.004</ArticleId><ArticleId IdType="pmc">PMC2391274</ArticleId><ArticleId IdType="pubmed">18279816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P., Lagier J.-C., Parola P., Hoang V.T., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020;56:105949. doi: 10.1016/j.ijantimicag.2020.105949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105949</ArticleId><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendrot M., Andreani J., Jardot P., Hutter S., Delandre O., Boxberger M., Mosnier J., Le Bideau M., Duflot I., Fonta I., et al. In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2. Molecules. 2020;25:5064. doi: 10.3390/molecules25215064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25215064</ArticleId><ArticleId IdType="pmc">PMC7663271</ArticleId><ArticleId IdType="pubmed">33142770</ArticleId></ArticleIdList></Reference><Reference><Citation>Million M., Cortaredona S., Delorme L., Colson P., Levasseur A., Herv&#xe9; T.-D., Karim B., Salima L., Bernard La S., Laurence C.-J., et al. Early Treatment with Hydroxychloroquine and Azithromycin: A &#x2018;Real-Life&#x2019; Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients. medRxiv. 2023 doi: 10.1101/2023.04.03.23287649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.03.23287649</ArticleId></ArticleIdList></Reference><Reference><Citation>Madow B.P. Use of antimalarial drugs as &#x201c;desludging&#x201d; agents in vascular disease processes: Preliminary report. JAMA. 1960;172:1630&#x2013;1633. doi: 10.1001/jama.1960.03020150054010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1960.03020150054010</ArticleId><ArticleId IdType="pubmed">14419689</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchi E., Ferraris F. Desludging Action of Hydroxychloroquine in R.A. Acta Rheumatol. Scand. 1962;8:214&#x2013;221.</Citation></Reference><Reference><Citation>Edwards M.H., Pierangeli S., Liu X., Barker J.H., Anderson G., Harris E.N. Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice. Circulation. 1997;96:4380&#x2013;4384. doi: 10.1161/01.CIR.96.12.4380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.96.12.4380</ArticleId><ArticleId IdType="pubmed">9416907</ArticleId></ArticleIdList></Reference><Reference><Citation>Nallusamy S., Mannu J., Ravikumar C., Angamuthu K., Nathan B., Nachimuthu K., Ramasamy G., Muthurajan R., Subbarayalu M., Neelakandan K. Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening. Front. Pharmacol. 2021;12:667704. doi: 10.3389/fphar.2021.667704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.667704</ArticleId><ArticleId IdType="pmc">PMC8295902</ArticleId><ArticleId IdType="pubmed">34305589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalhor H., Sadeghi S., Abolhasani H., Kalhor R., Rahimi H. Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2&#x2009;S protein and human ACE2 interaction through virtual screening approaches. J. Biomol. Struct. Dyn. 2020;40:1299&#x2013;1315. doi: 10.1080/07391102.2020.1824816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1824816</ArticleId><ArticleId IdType="pmc">PMC7576931</ArticleId><ArticleId IdType="pubmed">32969333</ArticleId></ArticleIdList></Reference><Reference><Citation>Suravajhala R., Parashar A., Malik B., Nagaraj V.A., Padmanaban G., Kavi Kishor P.B., Polavarapu R., Suravajhala P. Comparative Docking Studies on Curcumin with COVID-19 Proteins. Preprints.Org. 2020 doi: 10.20944/preprints202005.0439.v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202005.0439.v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagisawa M., Foster P.J., Hanaki H., Omura S. Global Trends in Clinical Studies of Ivermectin in COVID-19. Jpn. J. Antibiot. 2021;74:44&#x2013;95.</Citation></Reference><Reference><Citation>Juarez M., Schcolnik-Cabrera A., Due&#xf1;as-Gonzalez A. The multitargeted drug ivermectin: From an antiparasitic agent to a repositioned cancer drug. Am. J. Cancer Res. 2018;8:317&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5835698</ArticleId><ArticleId IdType="pubmed">29511601</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W.C. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Curr. Pharm. Biotechnol. 2012;13:853&#x2013;865. doi: 10.2174/138920112800399095.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920112800399095</ArticleId><ArticleId IdType="pubmed">22039784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang M.W., Lindstrom W., Olson A.J., Belew R.K. Analysis of HIV Wild-Type and Mutant Structures via in Silico Docking against Diverse Ligand Libraries. J. Chem. Inf. Model. 2007;47:1258&#x2013;1262. doi: 10.1021/ci700044s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci700044s</ArticleId><ArticleId IdType="pubmed">17447753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta J., Sen U., Bakashi A., Dasgupta A. Nsp7 and Spike Glycoprotein of SARS-CoV-2 Are Envisaged as Potential Targets of Vitamin D and Ivermectin. Preprints.Org. 2020 doi: 10.20944/preprints202005.0084.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202005.0084.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussien M.A., Abdelaziz A.E.M. Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease. Netw. Model. Anal. Health Inform. Bioinform. 2020;9:56. doi: 10.1007/s13721-020-00263-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13721-020-00263-6</ArticleId><ArticleId IdType="pmc">PMC7413836</ArticleId><ArticleId IdType="pubmed">32834922</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur H., Shekhar N., Sharma S., Sarma P., Prakash A., Medhi B. Ivermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes. Pharmacol. Rep. 2021;73:736&#x2013;749. doi: 10.1007/s43440-020-00195-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-020-00195-y</ArticleId><ArticleId IdType="pmc">PMC7778723</ArticleId><ArticleId IdType="pubmed">33389725</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurya D. A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12630539.v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv.12630539.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha J.K., Raihan J. The Binding mechanism of Ivermectin and levosalbutamol with spike protein of SARS-CoV-2. Struct. Chem. 2021;32:1985&#x2013;1992. doi: 10.1007/s11224-021-01776-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11224-021-01776-0</ArticleId><ArticleId IdType="pmc">PMC8039806</ArticleId><ArticleId IdType="pubmed">33867777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S., Rheinstein P.H. Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2. In Vivo. 2020;34:3023&#x2013;3026. doi: 10.21873/invivo.12134.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12134</ArticleId><ArticleId IdType="pmc">PMC7652439</ArticleId><ArticleId IdType="pubmed">32871846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajter J.J. ((Broward Health Medical Center, Fort Lauderdale, FL, USA)). Personal communication. May 28, 2020.</Citation></Reference><Reference><Citation>Local Doctor Tries New Coronavirus Drug Treatment. NBC Miami News. Apr 14, 2020.  [(accessed on 30 October 2023)].  Available online:  https://www.nbcmiami.com/news/local/local-doctor-tries-new-coronavirus-drug-treatment/2219465/</Citation></Reference><Reference><Citation>Rajter J.C., Sherman M.S., Fatteh N., Vogel F., Sacks J., Rajter J.-J. Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study) Chest. 2020;159:85&#x2013;92. doi: 10.1016/j.chest.2020.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC7550891</ArticleId><ArticleId IdType="pubmed">33065103</ArticleId></ArticleIdList></Reference><Reference><Citation>Santin A.D., Scheim D.E., McCullough P.A., Yagisawa M., Borody T.J. Ivermectin: A multifaceted drug of Nobel prize-honored distinction with indicated efficacy against a new global scourge, COVID-19. New Microbes New Infect. 2021;43:100924. doi: 10.1016/j.nmni.2021.100924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100924</ArticleId><ArticleId IdType="pmc">PMC8383101</ArticleId><ArticleId IdType="pubmed">34466270</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdool Karim S.S., Devnarain N. Time to Stop Using Ineffective COVID-19 Drugs. N. Engl. J. Med. 2022;387:654&#x2013;655. doi: 10.1056/NEJMe2209017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2209017</ArticleId><ArticleId IdType="pubmed">36070715</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A., Teymouri Athar M.M., Kohandel Gargari O., Jafarabady K., Siahvoshi S., Mozhgani S.-H. Ivermectin under scrutiny: A systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients. Virol. J. 2022;19:102. doi: 10.1186/s12985-022-01829-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01829-8</ArticleId><ArticleId IdType="pmc">PMC9191543</ArticleId><ArticleId IdType="pubmed">35698151</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G., Moreira Silva E.A., Medeiros Silva D.C., Thabane L., Milagres A.C., Ferreira T.S., dos Santos C.V.Q., Campos V.H.S., Nogueira A.M.R., de Almeida A.P.F.G., et al. Effect of Early Treatment with Ivermectin among Patients with COVID-19. N. Engl. J. Med. 2022;386:1721&#x2013;1731. doi: 10.1056/NEJMoa2115869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2115869</ArticleId><ArticleId IdType="pmc">PMC9006771</ArticleId><ArticleId IdType="pubmed">35353979</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E., Aldous C., Osimani B., Fordham E.J., Hoy W.E. When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples. J. Clin. Med. 2023;12:3625. doi: 10.3390/jcm12113625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12113625</ArticleId><ArticleId IdType="pmc">PMC10253430</ArticleId><ArticleId IdType="pubmed">37297820</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food &amp; Drug Administration  Memorandum Explaining Basis for Declining Request for Emergency Use Authorization of Fluvoxamine Maleate.  [(accessed on 30 October 2023)]; Available online:  https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/EUA%20110%20Fluvoxamine%20Decisional%20Memo_Redacted.pdf.</Citation></Reference><Reference><Citation>NIH COVID-19 Treatment Guidelines  Fluvoxamine: Selected Clinical Data, Limitations and Interpretation. Table 4c.  [(accessed on 30 October 2023)];2021 December 16; Available online:  https://www.covid19treatmentguidelines.nih.gov/tables/fluvoxamine-data/</Citation></Reference><Reference><Citation>TOGETHER Trial DSS and Data Repository Screenshots  Date-Time Stamped Screenshots from Publications of the TOGETHER trial (NCT04727424)  [(accessed on 30 October 2023)].  Available online:  https://drive.google.com/file/d/1pBZ1GihxW_ROB3Aid6tFMplqAyMYOGDl/preview.</Citation></Reference><Reference><Citation>Email from Sarah Fullegar, Sent 7 June 2022 to Edmund Fordham, Screenshot, Email Addresses Redacted.  [(accessed on 30 October 2023)].  Available online:  https://drive.google.com/file/d/1lUsSRf1KX-pa9T5EX4HbegdK8mYNQ_Ty/preview.</Citation></Reference><Reference><Citation>L&#xf3;pez-Medina E., L&#xf3;pez P., Hurtado I.C., D&#xe1;valos D.M., Ramirez O., Mart&#xed;nez E., D&#xed;azgranados J.A., O&#xf1;ate J.M., Chavarriaga H., Herrera S., et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021;325:1426&#x2013;1435. doi: 10.1001/jama.2021.3071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3071</ArticleId><ArticleId IdType="pmc">PMC7934083</ArticleId><ArticleId IdType="pubmed">33662102</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E., Hibberd J.A., Chamie-Quintero J.J. Protocol Violations in L&#xf3;pez-Medina et al.: 38 Switched Ivermectin (IVM) and Placebo Doses, Failure of Blinding, Ubiquitous IVM use OTC in Cali, and Nearly Identical AEs for the IVM and Control Groups. OSF Preprints. 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.31219/osf.io/u7ewz</ArticleId></ArticleIdList></Reference><Reference><Citation>George L.L., Borody T.J., Andrews P., Devine M., Moore-Jones D., Walton M., Brandl S. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med. J. Aust. 1990;153:145&#x2013;149. doi: 10.5694/j.1326-5377.1990.tb136833.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1990.tb136833.x</ArticleId><ArticleId IdType="pubmed">1974027</ArticleId></ArticleIdList></Reference><Reference><Citation>Coghlan J.G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O&#x2019;Morain C. Campylobacter pylori and recurrence of duodenal ulcers&#x2014;A 12-month follow-up study. Lancet. 1987;2:1109&#x2013;1111. doi: 10.1016/S0140-6736(87)91545-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(87)91545-5</ArticleId><ArticleId IdType="pubmed">2890019</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham D.Y., Lew G.M., Klein P.D., Evans D.G., Evans D.J., Jr., Saeed Z.A., Malaty H.M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann. Intern. Med. 1992;116:705&#x2013;708. doi: 10.7326/0003-4819-116-9-705.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-116-9-705</ArticleId><ArticleId IdType="pubmed">1558340</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G. Nobel prize is awarded to doctors who discovered H pylori. BMJ. 2005;331:795. doi: 10.1136/bmj.331.7520.795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.331.7520.795</ArticleId><ArticleId IdType="pmc">PMC1246068</ArticleId><ArticleId IdType="pubmed">16210262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A. On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenz&#xe6;. Br. J. Exp. Pathol. 1929;10:226&#x2013;236. doi: 10.1093/clinids/2.1.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/2.1.129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chain E., Florey H.W., Gardner A.D., Heatley N.G., Jennings M.A., Orr-Ewing J., Sanders A.G. Penicillin as a chemotherapeutic agent. Lancet. 1940;236:226&#x2013;228. doi: 10.1016/S0140-6736(01)08728-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)08728-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobanovska M., Pilla G. Penicillin&#x2019;s Discovery and Antibiotic Resistance: Lessons for the Future? Yale J. Biol. Med. 2017;90:135&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5369031</ArticleId><ArticleId IdType="pubmed">28356901</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata A., Coppola A., Carannante N., Simioli F., Lanza M., Di Micco P., Fiorentino G. Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC. Pathogens. 2021;10:413. doi: 10.3390/pathogens10040413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10040413</ArticleId><ArticleId IdType="pmc">PMC8065650</ArticleId><ArticleId IdType="pubmed">33915796</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki R., Iwasawa T., Hagiwara E., Komatsu S., Utsunomiya D., Ogura T. Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity. Jpn. J. Radiol. 2021;39:451&#x2013;458. doi: 10.1007/s11604-020-01085-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-020-01085-2</ArticleId><ArticleId IdType="pmc">PMC7838849</ArticleId><ArticleId IdType="pubmed">33502657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Xu J., Zhou J., Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur. J. Radiol. 2020;127:109009. doi: 10.1016/j.ejrad.2020.109009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109009</ArticleId><ArticleId IdType="pmc">PMC7165099</ArticleId><ArticleId IdType="pubmed">32325282</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwally M.I., Basha M.A.A., Zaitoun M.M.A., Abdalla H.M., Nofal H.A.E., Hendawy H., Manajrah E., Hijazy R.f., Akbazli L., Negida A., et al. Clinical and radiological imaging as prognostic predictors in COVID-19 patients. Egypt. J. Radiol. Nucl. Med. 2021;52:100. doi: 10.1186/s43055-021-00470-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-021-00470-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman A.M., Farouk S., Osman N.M., Abdrabou A.M. Longitudinal assessment of chest computerized tomography and oxygen saturation for patients with COVID-19. Egypt. J. Radiol. Nucl. Med. 2020;51:255. doi: 10.1186/s43055-020-00376-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00376-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Quispe-Cholan A., Anticona-De-La-Cruz Y., Cornejo-Cruz M., Quispe-Chirinos O., Moreno-Lazaro V., Chavez-Cruzado E. Tomographic findings in patients with COVID-19 according to evolution of the disease. Egypt. J. Radiol. Nucl. Med. 2020;51:215. doi: 10.1186/s43055-020-00329-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00329-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Dong C., Hu Y., Li C., Ren Q., Zhang X., Shi H., Zhou M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020;296:e55&#x2013;e64. doi: 10.1148/radiol.2020200843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200843</ArticleId><ArticleId IdType="pmc">PMC7233482</ArticleId><ArticleId IdType="pubmed">32191587</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J.C., Ndarukwa P., Scheim D.E., Dancis B.M., Dancis J., Gill M.G., Aldous C. Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours. Biologics. 2022;2:196&#x2013;210. doi: 10.3390/biologics2030015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biologics2030015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S., Dave S., Gunaratne A.W., Dolai S., Clancy R.L., McCullough P.A., Borody T.J. Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients. Future Microbiol. 2022;17:339&#x2013;350. doi: 10.2217/fmb-2022-0014.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0014</ArticleId><ArticleId IdType="pmc">PMC8826831</ArticleId><ArticleId IdType="pubmed">35135310</ArticleId></ArticleIdList></Reference><Reference><Citation>Babalola O.E., Ndanusa Y., Adesuyi A., Ogedengbe O.J., Thairu Y., Ogu O. A Randomized Controlled Trial of Ivermectin Monotherapy Versus HCQ, IVM, and AZ Combination Therapy in COVID-19 Patients in Nigeria. J. Infect. Dis. Epidemiol. 2021;7:233. doi: 10.23937/2474-3658/1510233.</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2474-3658/1510233</ArticleId></ArticleIdList></Reference><Reference><Citation>Babalola O.E. ((Bingham University, New Karu, Nigeria)). Personal communication. Feb 28, 2022.</Citation></Reference><Reference><Citation>Thairu Y., Babalola O.E., Ajayi A.A., Ndanusa Y., Ogedengbe J.O., Omede O. A comparison of Ivermectin and Non Ivermectin based regimen for COVID-19 in Abuja: Effects on virus clearance, Days-to-Discharge and Mortality. Res. Sq. 2022;34:1&#x2013;19. doi: 10.9734/jpri/2022/v34i44A36328.</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/jpri/2022/v34i44A36328</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamie J.J., Hibberd J.A., Scheim D.E. COVID-19 Excess Deaths in Peru&#x2019;s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State. Cureus. 2023;15:e43168. doi: 10.7759/cureus.43168.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.43168</ArticleId><ArticleId IdType="pmc">PMC10484241</ArticleId><ArticleId IdType="pubmed">37692571</ArticleId></ArticleIdList></Reference><Reference><Citation>Meekins D.A., Gaudreault N.N., Richt J.A. Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals. Viruses. 2021;13:1993. doi: 10.3390/v13101993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101993</ArticleId><ArticleId IdType="pmc">PMC8540328</ArticleId><ArticleId IdType="pubmed">34696423</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskurt O.K., Meiselman H.J. Comparative hemorheology. Clin. Hemorheol. Microcirc. 2013;53:61&#x2013;70. doi: 10.3233/CH-2012-1576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-2012-1576</ArticleId><ArticleId IdType="pubmed">22951622</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampling M.W., Meiselman H.J., Neu B., Baskurt O.K. Influence of cell-specific factors on red blood cell aggregation. Biorheology. 2004;41:91&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090679</ArticleId></ArticleIdList></Reference><Reference><Citation>Popel A.S., Johnson P.C., Kameneva M.V., Wild M.A. Capacity for red blood cell aggregation is higher in athletic mammalian species than in sedentary species. J. Appl. Physiol. (1985) 1994;77:1790&#x2013;1794. doi: 10.1152/jappl.1994.77.4.1790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1994.77.4.1790</ArticleId><ArticleId IdType="pubmed">7836201</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng X., Cloutier G., Pibarot P., Durand L.G. Comparison and simulation of different levels of erythrocyte aggregation with pig, horse, sheep, calf, and normal human blood. Biorheology. 1996;33:365&#x2013;377. doi: 10.3233/BIR-1996-334-506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BIR-1996-334-506</ArticleId><ArticleId IdType="pubmed">8977661</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernike K., B&#xf6;ttcher J., Amelung S., Albrecht K., G&#xe4;rtner T., Donat K., Beer M. Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany. Emerg. Infect. Dis. J. 2022;28:1916. doi: 10.3201/eid2809.220125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2809.220125</ArticleId><ArticleId IdType="pmc">PMC9423924</ArticleId><ArticleId IdType="pubmed">35914515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco-Lauth A.M., Walker A., Guilbert L., Porter S., Hartwig A., McVicker E., Bielefeldt-Ohmann H., Bowen R.A. Susceptibility of livestock to SARS-CoV-2 infection. Emerg. Microbes Infect. 2021;10:2199&#x2013;2201. doi: 10.1080/22221751.2021.2003724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2003724</ArticleId><ArticleId IdType="pmc">PMC8635583</ArticleId><ArticleId IdType="pubmed">34749583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessa.net Free Statistics Software, Office for Research Development and Education, Version 1.2.1.  [(accessed on 30 October 2023)].  Available online:  https://www.wessa.net/</Citation></Reference><Reference><Citation>Nemkov T., Reisz J.A., Xia Y., Zimring J.C., D&#x2019;Alessandro A. Red blood cells as an organ? How deep omics characterization of the most abundant cell in the human body highlights other systemic metabolic functions beyond oxygen transport. Expert Rev. Proteom. 2018;15:855&#x2013;864. doi: 10.1080/14789450.2018.1531710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2018.1531710</ArticleId><ArticleId IdType="pubmed">30278801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14:e1002533. doi: 10.1371/journal.pbio.1002533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002533</ArticleId><ArticleId IdType="pmc">PMC4991899</ArticleId><ArticleId IdType="pubmed">27541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang V.T., Crispin M., Aricescu A.R., Harvey D.J., Nettleship J.E., Fennelly J.A., Yu C., Boles K.S., Evans E.J., Stuart D.I., et al. Glycoprotein structural genomics: Solving the glycosylation problem. Structure. 2007;15:267&#x2013;273. doi: 10.1016/j.str.2007.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2007.01.011</ArticleId><ArticleId IdType="pmc">PMC1885966</ArticleId><ArticleId IdType="pubmed">17355862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.E., Fusco M.L., Saphire E.O. An efficient platform for screening expression and crystallization of glycoproteins produced in human cells. Nat. Protoc. 2009;4:592&#x2013;604. doi: 10.1038/nprot.2009.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.29</ArticleId><ArticleId IdType="pmc">PMC2911120</ArticleId><ArticleId IdType="pubmed">19373230</ArticleId></ArticleIdList></Reference><Reference><Citation>Dill K., Hu S.H., Berman E., Pavia A.A., Lacombe J.M. One- and two-dimensional NMR studies of the N-terminal portion of glycophorin A at 11.7 Tesla. J. Protein Chem. 1990;9:129&#x2013;136. doi: 10.1007/BF01025303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01025303</ArticleId><ArticleId IdType="pubmed">2386609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekman S., Flower R., Mahler S., Gould A., Barnard R.T., Hyland C., Jones M., Malde A.K., Bui X.T. In silico molecular dynamics of human glycophorin A (GPA) extracellular structure. Ann. Blood. 2021;6:1&#x2013;17. doi: 10.21037/aob-20-51.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/aob-20-51</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivedi R., Nagarajaram H.A. Intrinsically disordered proteins: An overview. Int. J. Mol. Sci. 2022;23:14050. doi: 10.3390/ijms232214050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232214050</ArticleId><ArticleId IdType="pmc">PMC9693201</ArticleId><ArticleId IdType="pubmed">36430530</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N., Dunker A.K. Understanding protein non-folding. Biochim. Biophys. Acta (BBA)-Proteins Proteom. 2010;1804:1231&#x2013;1264. doi: 10.1016/j.bbapap.2010.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2010.01.017</ArticleId><ArticleId IdType="pmc">PMC2882790</ArticleId><ArticleId IdType="pubmed">20117254</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N., Gillespie J.R., Fink A.L. Why are &#x201c;natively unfolded&#x201d; proteins unstructured under physiologic conditions? Proteins. 2000;41:415&#x2013;427. doi: 10.1002/1097-0134(20001115)41:3&lt;415::AID-PROT130&gt;3.0.CO;2-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0134(20001115)41:3&lt;415::AID-PROT130&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">11025552</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet R.C.S., Quek A.M.L., Ooi D.S.Q., Sengupta S., Lakshminarasappa S.R., Koo C.Y., So J.B.Y., Goh B.C., Loh K.S., Fisher D., et al. Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial. Int. J. Infect. Dis. 2021;106:314&#x2013;322. doi: 10.1016/j.ijid.2021.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.035</ArticleId><ArticleId IdType="pmc">PMC8056783</ArticleId><ArticleId IdType="pubmed">33864917</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R. Offline: What is medicine&#x2019;s 5 sigma? Lancet. 2015;385:1380. doi: 10.1016/S0140-6736(15)60696-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60696-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis J.P. Evidence-based medicine has been hijacked: A report to David Sackett. J. Clin. Epidemiol. 2016;73:82&#x2013;86. doi: 10.1016/j.jclinepi.2016.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.02.012</ArticleId><ArticleId IdType="pubmed">26934549</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbrook R., Kassirer J.P., Angell M. Justifying conflicts of interest in medical journals: A very bad idea. BMJ. 2015;350:h2942. doi: 10.1136/bmj.h2942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h2942</ArticleId><ArticleId IdType="pubmed">26036926</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle J.B. False individual patient data and zombie randomised controlled trials submitted to Anaesthesia. Anaesthesia. 2021;76:472&#x2013;479. doi: 10.1111/anae.15263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15263</ArticleId><ArticleId IdType="pubmed">33040331</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotzsche P. Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare. 1st ed. CRC Press; London, UK: 2013.</Citation></Reference><Reference><Citation>Saltelli A., Dankel D.J., Di Fiore M., Holland N., Pigeon M. Science, the endless frontier of regulatory capture. Futures. 2022;135:102860. doi: 10.1016/j.futures.2021.102860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.futures.2021.102860</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslick G.D., Tilden D., Arora N., Torres M., Clancy R.L. Clinical and economic impact of &#x201c;triple therapy&#x201d; for Helicobacter pylori eradication on peptic ulcer disease in Australia. Helicobacter. 2020;25:e12751. doi: 10.1111/hel.12751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hel.12751</ArticleId><ArticleId IdType="pubmed">32820568</ArticleId></ArticleIdList></Reference><Reference><Citation>Berndt E.R., Kyle M., Ling D. The Long Shadow of Patent Expiration: Generic Entry and Rx-to-OTC Switches. In: Feenstra R.C., Shapiro M.D., editors. Scanner Data and Price Indexes. University of Chicago Press; Chicago, IL, USA: 2003. pp. 229&#x2013;274.</Citation></Reference><Reference><Citation>Chatterjee S., Bhattacharya M., Nag S., Dhama K., Chakraborty C. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses. 2023;15:167. doi: 10.3390/v15010167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010167</ArticleId><ArticleId IdType="pmc">PMC9866114</ArticleId><ArticleId IdType="pubmed">36680207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui K.P.Y., Ho J.C.W., Cheung M.-c., Ng K.-c., Ching R.H.H., Lai K.-l., Kam T.T., Gu H., Sit K.-Y., Hsin M.K.Y., et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603:715&#x2013;720. doi: 10.1038/s41586-022-04479-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId><ArticleId IdType="pubmed">35104836</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock T.P., Brown J.C., Zhou J., Thakur N., Sukhova K., Newman J., Kugathasan R., Yan A.W.C., Furnon W., De Lorenzo G., et al. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein. bioRxiv. 2022 doi: 10.1101/2021.12.31.474653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.31.474653</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo F., Walters K.-A., Xiao Y., Sheng Z.-M., Scherler K., Park J., Gygli S., Rosas L.A., Sadtler K., Kalish H., et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 2021;13:eabj7790. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Makary M. The Real Data Behind the New COVID Vaccines the White Houseis Pushing. New York Post. Sep 14, 2023.  [(accessed on 30 October 2023)].  Available online:  https://nypost.com/2023/09/14/the-real-data-behind-the-new-covid-vaccines-the-white-house-is-pushing/</Citation></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.M., Puskarich M.A., Cohen K., Belani H.K., Anderson B.J., Huling J.D., Tignanelli C.J., et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis. 2023;23:1119&#x2013;1129. doi: 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy M.W., Naggie S., Boulware D.R., Lindsell C.J., Stewart T.G., Felker G.M., Jayaweera D., Sulkowski M., Gentile N., Bramante C., et al. Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2023;329:296&#x2013;305. doi: 10.1001/jama.2022.24100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.24100</ArticleId><ArticleId IdType="pmc">PMC9857647</ArticleId><ArticleId IdType="pubmed">36633838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., et al. Nicotinic acetylcholine receptor &#x3b1;7 subunit is an essential regulator of inflammation. Nature. 2003;421:384&#x2013;388. doi: 10.1038/nature01339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01339</ArticleId><ArticleId IdType="pubmed">12508119</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause R.M., Buisson B., Bertrand S., Corringer P.J., Galzi J.L., Changeux J.P., Bertrand D. Ivermectin: A positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 1998;53:283&#x2013;294. doi: 10.1124/mol.53.2.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.53.2.283</ArticleId><ArticleId IdType="pubmed">9463487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>